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Figure S1. Structure of compound 33 in the solid state, showing the disorder of the C4-C6 region 


































Figure S2. Structure of the head-to-tail cyclodimer formed as a minor by-product upon metathesis of 
alkynoate 48a. 
 
X-ray Crystal Structure Analysis of Compound 33: C24 H36 O5 Si, Mr = 432.62  g · mol
-1, colorless block, 
crystal size 0.403 x 0.161 x 0.119 mm, orthorhombic, space group P212121, a = 7.8769(7) Å, b = 
10.6641(10) Å, c = 28.818(3) Å, V = 2420.8(4) Å3, T = 100 K, Z = 4, Dcalc = 1.187  g · cm
3,  = 1.54178 Å, 
(Cu-K) = 1.102 mm-1, Semi-empirical absorption correction (Tmin = 0.72, Tmax = 0.88), Bruker AXS X8 
Proteum diffractometer, 3.07 <  < 67.11, 105639 measured reflections, 4259 independent 
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reflections, 4228 reflections with I > 2(I), Structure solved by direct methods and refined by full-
matrix least-squares against F2 to R1 = 0.024 [I > 2(I)], wR2 = 0.065, absolute structure parameter = 
0.015(18), 297 parameters, H atoms riding, S = 1.047, residual electron density +0.2 / -0.2 e Å-3. 
 
X-ray Crystal Structure Analysis of Compound 25: C17 H28 O4, Mr = 296.39  g · mol
-1, colorless block, 
crystal size 0.25 x 0.23 x 0.11 mm, monoclinic, space group P21/n, a = 8.5595(7) Å, b = 9.7342(7) Å, c 
= 20.3518(14) Å, β = 100.851(7)°, V = 1665.4(2) Å3, T = 100 K, Z = 4, Dcalc = 1.182  g · cm
3,  = 0.71073 
Å, (Mo-K) = 0.082 mm-1, Semi-empirical absorption correction (Tmin = 0.97, Tmax = 0.99), Nonius 
KappaCCD diffractometer, 2.80 <  < 33.06, 29258 measured reflections, 6281 independent 
reflections, 4672 reflections with I > 2(I), Structure solved by direct methods and refined by full-
matrix least-squares against F2 to R1 = 0.067 [I > 2(I)], wR2 = 0.179, extinction coefficient = 
0.0084(13), 190 parameters, H atoms riding, S = 1.067, residual electron density +1.1 / -0.4 e Å-3. 
 
X-ray Crystal Structure Analysis of Compound 39: C32 H48 O4, Mr = 496.70  g · mol
-1, colorless block, 
crystal size 0.25 x 0.06 x 0.06 mm, orthorhombic, space group P21212, a = 13.0760(8) Å Å, b = 
23.4954(13) Å, c = 4.8287(3) Å, V = 1483.50(15) Å3, T = 100 K, Z = 2, Dcalc = 1.112  g · cm
3,  = 1.54178 
Å, (Cu-K) = 0.556 mm
-1, Semi-empirical absorption correction (Tmin = 0.90, Tmax = 0.97), Bruker AXS 
X8 Proteum diffractometer, 3.76 <  < 61.15, 18776 measured reflections, 2120 independent 
reflections, 1323 reflections with I > 2(I), Structure solved by direct methods and refined by full-
matrix least-squares against F2 to R1 = 0.054 [I > 2(I)], wR2 = 0.129, absolute structure parameter = 
0.1(5), extinction coefficient = 0.0220(16), 165 parameters, H atoms riding, S = 0.931, residual 
electron density +0.2 / -0.2 e Å-3. 
 
X-ray Crystal Structure Analysis of the Cyclodimer (Figure S2): C26 H40 O4, Mr = 416.58  g · mol
-1, 
colorless block, crystal size 0.20 x 0.14 x 0.06 mm, monoclinic, space group P2/n, a = 9.1055(15) Å, b 
= 5.2069(9) Å, c = 24.954(4) Å, β = 93.551(3)°, V = 1180.8(3) Å3, T = 100 K, Z = 2, Dcalc = 1.172  g · cm
3, 
 = 0.71073 Å, (Mo-K) = 0.077 mm-1, Semi-empirical absorption correction (Tmin = 0.99, Tmax = 1.00), 
Bruker-AXS APEX-II diffractometer, 1.635 <  < 31.632, 32308 measured reflections, 3979 
independent reflections, 3412 reflections with I > 2(I), Structure solved by direct methods and 
refined by full-matrix least-squares against F2 to R1 = 0.051 [I > 2(I)], wR2 = 0.149, 136 parameters, H 
atoms riding, S = 1.218, residual electron density +0.4 / -0.3 e Å-3. 
 
CCDC 936549 (33), 936550 (25), 936551 (39) and 944741 (cyclodimer, Figure S2) contain the 
supporting crystallographic data for this paper. These data can be obtained free of charge from the 







General. All reactions were carried out under Ar in flame-dried glassware. The solvents used were 
purified by distillation over the drying agents indicated and were transferred under Ar: THF, Et2O, 
CH2Cl2, hexane, toluene (Na/K), MeOH (Mg). Flash chromatography (FC): Merck silica gel 60 (230–400 
mesh). NMR: Spectra were recorded on Bruker PX 300, AMX 300, AV 400, or AV 600 spectrometer in 
the solvents indicated; chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in 
Hz. The solvent signals were used as references and the chemical shifts converted to the TMS scale 
(CDCl3: δC ≡ 77.0 ppm; residual CHCl3 in CDCl3: δH ≡ 7.26 ppm; [D6]-acetone: δC ≡ 205.87 ppm; residual 
(CH3)2CO in [D6]-acetone: δH ≡ 2.09 ppm). IR: Spectrum One (Perkin-Elmer) spectrometer, 
wavenumbers (~ ) in cm−1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ 3000 (Bruker), accurate 
mass determinations: Bruker APEX III FT-MS (7 T magnet) or Mat 95 (Finnigan). Unless stated 
otherwise, all commercially available compounds (Fluka, Lancaster, Aldrich) were used as received. 
DBU was dried over CaH2, whereas the molecular sieves were dried by heating (280°C, sand bath) in 





Compound 8. CsF (152 mg, 1.00 mmol) was added to a solution of ester 7 (1.68 g, 10.0 mmol)1 and 
tridec-11-yn-1-ol (2.45 g, 12.5 mmol) in toluene and the resulting suspension 
was stirred at reflux temperature for 18 h. For work up, the mixture was 
allowed to cool before it was filtered through a silica pad, which was rinsed 
with EtOAc. The combined filtrates were evaporated and the residue purified by 
flash chromatography (hexanes/EtOAc, 9:1) to give ester 8 as a colorless syrup (2.75 g, 83%). The 
product partly exists in enolized form. 1H NMR (400 MHz, CDCl3): δ = 4.12 (t, J = 6.8 Hz, 2H), 3.45 (s, 
2H), 2.74 (t, J = 7.3 Hz, 2H), 2.40 (tq, J = 7.6, 2.5 Hz, 2H), 2.10 (tq, J = 7.2 Hz, 2.5 Hz, 2H), 1.77 (t, J = 2.5 
Hz, 3H), 1.74 (t, J = 2.5 Hz, 3H), 1.67 - 1.59 (m, 2H), 1.50 - 1.41 (m, 2H), 1.38 - 1.23 (m, 12H); 13C NMR 
(100 MHz, CDCl3): δ = 201.1, 167.0, 79.4, 77.1, 76.4, 75.3, 65.6, 49.2, 42.2, 29.4 (2C), 29.2, 29.1, 29.0, 
28.9, 28.5, 25.8, 18.7, 13.2, 3.4 (2C); IR (film): ṽ = 2915, 2850, 1738, 1704, 1469, 1434, 1411, 1371, 
1332, 1281, 1253, 1191, 1133, 1087, 1040, 1020, 985, 970, 923, 787, 755, 721 cm-1; MS (EI): m/z (%): 
332 (2) [M]+, 317 (5), 161 (9), 154 (12), 153 (25), 147 (12), 137 (14), 134 (10), 133 (15), 121 (17), 120 
(19), 119 (20), 110 (17), 109 (26), 108 (18), 107 (18), 95 (69), 94 (11), 93 (22), 83 (10), 81 (46), 80 (11), 
79 (27), 69 (44), 68 (45), 67 (100), 66 (25), 65 (13), 55 (74), 54 (14), 53 (30), 43 (34), 42 (11), 41 (72), 
39 (13), 29 (13), 27 (10); HRMS (EI): m/z: calcd for C21H32O3: 332.2351; found: 332.2352.  
Cycloalkyne 9. Et3N (83 µL, 600 µmol) was added to a solution of compound 8 (166 mg, 500 µmol) in 
CH2Cl2 (2 mL), followed by slow addition of TMSCl (70 µL, 550 µmol). The resulting 
mixture was stirred overnight before all volatile materials were pumped off in 
vacuum (10-3 mbar). The residue was dissolved in toluene (250 mL), MS 5Å (1 g) 
was added and the resulting suspension stirred for 10 min before a solution of 
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  S. Trudeau, P. Deslongschamps, J. Org. Chem. 2004, 69, 832-838. 
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complex 2∙Et2O (27.1 mg, 25 µmol) in toluene (1 mL) was introduced. After stirring for 16 h at 80°C, 
additional catalyst (27.1 mg, 25 µmol) in toluene (1 mL) was added and stirring continued for another 
4 h at 80°C.2 The mixture was then filtered through a pad of silica, the filtrate was evaporated, and 
the residue purified by flash chromatography (hexanes/acetone, 15:1) to furnish cycloalkyne 9 as a 
colorless solid (125 mg, 90%). The product partly exists in enolized form. Mp = 40-41 °C; 1H NMR (400 
MHz, CDCl3): δ = 4.20 (t, J = 5.8 Hz, 2H), 3.44 (s, 2H), 2.78 - 2.73 (m, 2H), 2.45 - 2.39 (m, 2H), 2.17 - 
2.13 (m, 2H), 1.71 - 1.62 (m, 2H), 1.47 - 1.37 (m, 6H), 1.37 - 1.29 (m, 8H); 13C NMR (100 MHz, CDCl3): δ 
= 200.7, 167.0, 81.1, 78.5, 65.4, 49.9, 41.9, 28.1, 27.6 (2C), 27.4, 27.3, 27.0, 26.7, 25.3, 18.3, 13.3; IR 
(film): ṽ = 2966, 2924, 2852, 1742, 1713, 1689, 1469, 1443, 1428, 1402, 1391, 1367, 1336, 1312, 
1269, 1240, 1203, 1144, 1125, 1080, 1038, 1018, 995, 978, 955, 929, 914, 892, 868, 816, 784, 726, 
704 cm-1; MS (EI): m/z (%): 278 (39) [M]+, 250 (9), 234 (17), 193 (10), 176 (10), 165 (32), 153 (38), 152 
(48), 149 (39), 139 (30), 135 (27), 121 (24), 119 (20), 109 (68), 108 (26), 107 (61), 105 (20), 96 (23), 95 
(27), 94 (42), 93 (43), 91 (39), 87 (20), 81 (43), 80 (32), 79 (73), 77 (32), 69 (47), 67 (60), 65 (24), 55 
(96), 53 (24), 43 (47), 42 (22), 41 (100), 39 (25), 29 (30); HRMS (ESI+): m/z: calcd for C17H26O3+Na: 
301.1774; found: 301.1775.  
Compound 11. AgNTf2 (10.7 mg, 27.5 µmol) was added to a solution of Ph3PAuCl (15.0 mg, 30.3 
µmol) in CH2Cl2 (0.9 mL) and the resulting suspension stirred for 15 min before 
the precipitate was allowed to settle. The supernatant was transferred via canula 
into a solution of cycloalkyne 9 (153 mg, 550 µmol) in CH2Cl2 (1.8 mL). The 
resulting mixture was stirred for 16 h before it was passed through a pad consisting of a layer of silica 
and a layer of Celite. The filtrate was evaporated and the residue purified by flash chromatography 
(hexanes/EtOAc, 3:1) to give the title compound as a colorless solid (149 mg, 97%). Mp = 69-70 °C; 1H 
NMR (400 MHz, CDCl3): δ = 4.31 (t, J = 5.5 Hz, 2H), 2.42 (t, J = 6.7 Hz, 2H), 2.38 (t, J = 6.1 Hz, 2H), 2.29 
- 2.23 (m, 2H), 2.04 - 1.96 (m, 2H), 1.73 - 1.66 (m, 2H), 1.59 - 1.50 (m, 2H), 1.46 - 1.22 (m, 12H); 13C 
NMR (100 MHz, CDCl3): δ = 195.5, 167.4, 163.2, 133.3, 64.0, 37.0, 35.0, 29.0, 27.4, 27.3, 25.7, 25.3, 
24.7, 24.3, 23.9, 22.1, 21.9; IR (film): ṽ = 3526, 3317, 2927, 2906, 2852, 2683, 1715, 1667, 1617, 1460, 
1440, 1433, 1420, 1385, 1368, 1345, 1328, 1302, 1268, 1239, 1206, 1185, 1170, 1153, 1145, 1104, 
1070, 1062, 1040, 1028, 965, 948, 925, 897, 880, 802, 775, 762, 734, 703, 694 cm-1; MS (EI): m/z (%): 
278 (9) [M]+, 163 (7), 149 (12), 136 (10), 110 (8), 79 (18), 77 (11), 69 (12), 67 (18), 66 (10), 55 (100), 53 
(19), 43 (30), 42 (19), 41 (98), 39 (25), 29 (38), 27 (26); HRMS (ESI+): m/z: calcd for C17H26O3 +Na: 
301.1774; found: 301.1772.  
Compound 12. TMSCl (98 µL, 770 µmol) and DDQ (175 mg, 770 µmol) were added at 20°C to a 
solution of compound 11 (195 mg, 700 µmol) in MeCN (2.8 mL) in a pressure 
tube, which was tightly closed. The mixture was allowed to reach ambient 
temperature overnight before it was stirred for 6 h at 90°C. After cooling to 
ambient temperature, the mixture was diluted with acetone until all insoluble materials had 
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  Since the substrate and the product could not be distinguished by TLC, the second crop was added to 
ensure that no trace of starting material remained; no attempt was made to check whether this 
replenishing is actually necessary. 
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dissolved, and the resulting solution was adsorped onto silica. The loaded silica was added on top of 
a flash column loaded with silica and the product was eluted with hexane/EtOAc (15:1  6:1) to give 
product 12 as a colorless solid (92.5 mg, 48%, 67% brsm) and recovered starting material (54.0 mg, 
28%). Mp = 73-74 °C; 1H NMR (400 MHz, CDCl3): δ = 11.26 (s, 1H), 7.29 (t, J = 7.9 Hz, 1H), 6.83 (dd, J = 
8.3, 1.1 Hz, 1H), 6.74 (dd, J = 7.6, 1.1 Hz, 1H), 4.44 - 4.41 (m, 2H), 2.88 - 2.82 (m, 2H), 1.84 - 1.76 (m, 
2H), 1.63 - 1.32 (m, 14H); 13C NMR (100 MHz, CDCl3): δ = 172.1, 162.4, 146.1, 134.0, 122.4, 115.4, 
112.3, 66.1, 36.5, 31.2, 27.3, 27.0, 26.5, 26.2, 23.6, 23.1, 22.9; IR (film): ṽ = 2941, 2915, 2899, 2846, 
1952, 1868, 1652, 1606, 1572, 1470, 1441, 1388, 1373, 1342, 1310, 1292, 1256, 1241, 1213, 1204, 
1164, 1141, 1124, 1101, 1071, 1048, 1030, 1019, 976, 936, 910, 885, 863, 815, 802, 789, 769, 756, 
712 cm-1; MS (EI): m/z (%): 277 (20), 276 (100) [M]+, 258 (20), 240 (10), 211 (11), 197 (14), 173 (18), 
162 (27), 161 (37), 160 (16), 152 (53), 148 (28), 147 (51), 146 (32), 135 (16), 134 (65), 107 (14), 105 
(19), 91 (13), 77 (16), 55 (27), 41 (34); HRMS (ESI+): m/z: calcd for C17H24O3 +Na: 299.1618; found: 
299.1617. 
Methyl 3-oxo-13-pentadecynoate (S1). Methyl acetoacetate (581 mg, 5.00 mmol) was slowly added 
at 0°C to a suspension of NaH (132 mg, 5.50 mmol) in THF (10 mL). Once the 
additon of gas had ceased, n-BuLi (1.6 M in hexane, 3.28 mL, 5.25 mmol) was 
introduced  and stirring continued for 15 min at 0°C before 11-bromo-2-undecyne 
(1.21 g, 5.25 mmol) was added. After stirring for 16 h at ambient temperature, the 
reaction was quenched with aq. HCl (1 M). The aqueous layer was extracted with 
Et2O, the combined extracts were dried over Na2SO4 and evaporated, and the residue was purified by 
flash chromatography (pentane/Et2O, 7:1) to give the title compound as a colorless solid (701 mg, 
53%). Mp = 39-40 °C; 1H NMR (400 MHz, CDCl3): δ = 3.72 (s, 3H), 3.43 (s, 2H), 2.51 (t, J = 7.4 Hz, 2H), 
2.09 (tq, J = 7.2, 2.6 Hz, 2H), 1.76 (t, J = 2.6 Hz, 3H), 1.61 - 1.53 (m, 2H), 1.48 - 1.39 (m, 2H), 1.38 - 1.22 
(m, 10H); 13C NMR (100 MHz, CDCl3): δ = 202.7, 167.6, 79.3, 75.3, 52.3, 49.0, 43.0, 29.2 (2C), 29.0 
(2C), 28.9, 28.8, 23.4, 18.7, 3.4; IR (film): ṽ = 2934, 2916, 2848, 1743, 1708, 1469, 1438, 1406 1379, 
1370, 1356, 1336, 1317, 1274, 1257, 1232, 1198, 1159, 1110, 1089, 1072, 1011, 1002, 983, 949, 896, 
861, 833, 718, 657 cm-1; MS (EI): m/z (%): 266 (2) [M]+, 235 (5), 199 (10), 175 (6), 174 (7), 150 (6), 149 
(6), 138 (5), 135 (9), 129 (32), 121 (14), 116 (63), 109 (21), 101 (37), 97 (15), 95 (52), 93 (19), 84 (17), 
81 (41), 79 (23), 74 (23), 69 (44), 68 (100), 67 (44), 59 (25), 55 (60), 53 (22), 43 (35), 41 (45), 29 (15); 
HRMS (ESI+): m/z: calcd for C16H26O3+Na: 289.1774; found: 289.1775. 
Compound 14. A solution of compound S1 (559 mg, 2.10 mmol) in THF (4 mL) was slowly added at 
0°C to a suspension of NaH (50.4 mg, 2.10 mmol) in THF (4.2 mL). After stirring for 
30 min at this temperature, 1-bromo-2-butyne (190 µl, 2.10 mmol) was introduced 
and the resulting mixture stirred for 16 h at ambient temperature. The reaction was 
quenched with aq. HCl (1 M). The aqueous layer was extracted with Et2O, the 
combined extracts were dried over Na2SO4 and evaporated, and the residue was 
purified by flash chromatography (hexane/EtOAc, 12:1) to give the title compound as a colorless solid 
(428 mg, 64%).  Mp = 40-41 °C; 1H NMR (400 MHz, CDCl3): δ = 3.71 (s, 3H), 3.64 (t, J = 7.6 Hz, 1H), 2.66 
- 2.47 (m, 4H), 2.08 (tq, J = 7.2, 2.5 Hz, 2H), 1.75 (t, J = 2.5 Hz, 3H), 1.71 (t, J = 2.5 Hz, 3H), 1.61 - 1.57 
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(m, 2H), 1.48 - 1.39 (m, 2H), 1.37 - 1.22 (m, 10H); 13C NMR (100 MHz, CDCl3): δ = 204.0, 168.9, 79.3, 
77.7, 75.3, 75.0, 57.8, 52.5, 42.6, 29.3 (2C), 29.1, 29.0, 28.9, 28.8, 23.3, 18.7, 180, 3.4 (2C); IR (film): ṽ 
= = 3010, 2920, 2849, 1735, 1707, 1649, 1616, 1463, 1454, 1439, 1431, 1401, 1370, 1354, 1341, 
1301, 1284, 1272, 1263, 1238, 1225, 1180, 1113, 1100, 1083, 1025, 1001, 972, 923, 867, 833, 812, 
726, 656 cm-1; MS (EI): m/z (%): 318 (8) [M]+, 287 (8), 286 (6), 259 (11), 193 (9), 175 (6), 168 (7), 161 
(8), 153 (6), 147 (13), 133 (11), 126 (11), 125 (100), 121 (10), 120 (11), 119 (12), 109 (19), 108 (15), 
107 (11), 95 (47), 93 (13), 81 (31), 79 (14), 69 (20), 68 (11), 67 (33), 55 (52), 53 (22), 43 (16), 41 (30); 
HRMS (ESI+): m/z: calcd for C20H30O3 +Na: 341.2087; found: 341.2087. 
Cycloalkyne 15. NEt3 (166 µL, 1.20 mmol) was added to a solution of compound 14 (319 mg, 1.00 
mmol) in CH2Cl2 (4 mL), followed by slow addition of TMSCl (140 µL, 1.20 mmol). The 
resulting mixture was stirred overnight before all volatile materials were pumped off 
in vacuum (10-3 mbar). The residue was dissolved in toluene (200 mL), MS 5Å (2 g) was 
added and the resulting suspension stirred for 10 min before a solution of complex 
2∙Et2O (54.3 mg, 50 µmol) in toluene (2 mL) was introduced. After stirring for 16 h at 80°C, additional 
catalyst (54.3 mg, 50 µmol) in toluene (2 mL) was added and stirring continued for another 6 h at 
80°C.2 The mixture was then filtered through a pad of silica, the filtrate was evaporated, and the 
residue purified by flash chromatography (hexanes/acetone, 10:1) to furnish cycloalkyne 15 as a 
colorless solid (173 mg, 66%). Mp = 38-39 °C; 1H NMR (400 MHz, CDCl3): δ = 3.69 (s, 3H), 3.77 (dd, J = 
12.0, 3.0 Hz, 1H), 2.95 (ddt, J = 16.7, 12.0, 2.4 Hz, 1H), 2.74 - 2.69 (m, 2H), 2.55 (ddt, J = 2.3, 3.0, 16.7 
Hz, 1H), 2.25 - 2.09 (m, 2H), 1.92 - 1.81 (m, 1H), 1.62 - 1.50 (m, 1H), 1.46 - 1.22 (m, 12H); 13C NMR 
(100 MHz, CDCl3): δ = 204.0, 168.6, 81.6, 76.7, 57.0, 52.6, 41.7, 26.9, 26.1, 25.9, 25.1, 25.0, 24.7, 22.3, 
17.8, 17.7; IR (film): ṽ = 2929, 2858, 1745, 1716, 1457, 1434, 1404, 1342, 1266, 1211, 1192, 1169, 
1107, 1078, 1021, 911, 858, 758, 709, 672 cm-1; MS (EI): m/z (%): 264 (11) [M]+, 233 (17), 205 (52), 
187 (25), 177 (17), 162 (32), 147 (25), 137 (59), 133 (34), 121 (37), 119 (45), 107 (39), 105 (36), 95 
(42), 94 (39), 93 (48), 91 (53), 81 (58), 80 (32), 79 (78), 77 (36), 69 (33), 67 (68), 66 (28), 65 (30), 59 
(25), 55 (95), 53 (27), 43 (35), 41 (100), 29 (34); HRMS (ESI+): m/z: calcd for C16H24O3 +Na: 287.1618; 
found: 287.1616. 
Furan (16). AuCl3 (12.1 mg, 40.0 µmol) was added to a solution of cycloalkyne 15 (150 mg, 566 µmol) 
in MeOH (3.0 mL) and the resulting mixture was stirred in a closed vessel at 70°C 
for 24 h. After reaching ambinet temperature, the mixture was adsorped on 
silica which was loaded on top of a flash column filled with silica. The product 
was eluted with pentanes/Et2O (30:1) to give furan 16 as a colorless oil (100 mg, 67%). 
1H NMR (400 
MHz, CDCl3): δ = 6.23 (s, 1H), 3.79 (s, 3H), 3.01 - 2.96 (m, 2H), 2.63 - 2.59 (m, 2H), 1.77 - 1.70 (m, 2H), 
1.69 - 1.62 (m, 2H), 1.37 - 1.18 (m, 12H); 13C NMR (100 MHz, CDCl3): δ = 164.7, 162.0, 154.5, 113.5, 
106.2, 51.1, 27.0, 26.9, 26.7, 26.6 (2C), 26.1, 26.0, 25.9, 25.8, 25.5; IR (film): ṽ = 2927, 2858, 1716, 
1613, 1574, 1459, 1437, 1392, 1338, 1300, 1281, 1206, 1151, 1092, 1064, 1027, 956, 806, 777, 700 
cm-1; MS (EI): m/z (%): m/z (%): 265 (18), 264 (100) [M]+, 249 (5), 233 (23), 232 (12), 221 (5), 205 (23), 
204 (16), 203 (6), 189 (5), 187 (14), 186 (8), 179 (7), 168 (5), 166 (8), 165 (22), 154 (7), 153 (15), 152 
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(26), 147 (5), 135 (5), 122 (6), 121 (5), 94 (8), 55 (9), 41 (10), 29 (6); HRMS (ESI+): m/z: calcd for 
C16H24O3+Na: 287.1618; found: 287.1618. 
Representative Alkyne Metathesis Reaction of a Propargyl Alcohol Derivative (Table 1, entry 1). A 
stock solution of complex 2∙Et2O (0.01 M in toluene, 0.50 mL, 5.0 μmol) was added to 
a solution of diyne 17a (0.020 g, 0.050 mmol) in toluene (2.5 mL), containing 
activated MS 5Å powder (300 mg). The suspension was stirred overnight at ambient 
temperature before it was filtered, the filtrate was evaporated and the residue 
purified by flash chromatography (hexane/EtOAc, 10:1) to give product 18a  as a 
colorless oil (12.1 mg, 69%).1H NMR (400 MHz, CDCl3): δ = 4.40-4.32 (m, 1H), 4.19-4.07 (m, 2H), 2.64-
2.50 (m, 2H), 2.42-2.32 (m, 2H), 1.74-1.50 (m, 4H), 1.50-1.20 (m, 10H), 0.87 (s, 9H), 0.09 (s, 3H), 0.08 
(s, 3H); 13C NMR (100 MHz, CDCl3): δ = 174.2, 82.5, 81.5, 63.5, 63.2, 38.1, 33.3, 27.1, 26.8, 26.1, 25.9, 
25.7, 24.9, 22.7, 19.2, 18.3, –4.6, –4.9; IR (film): ν~  = 2929, 2858, 1737, 1462, 1386, 1339, 1250, 1176, 
1104, 1074, 1006, 938, 836, 777, 665 cm-1; MS (EI): m/z (%): 337 (2), 295 (100), 265 (2), 225 (4), 185 
(2), 155 (2), 127 (4), 105 (3), 91 (3), 75 (13), 55 (2), 41 (1); HRMS (ESI+): m/z: calcd for C20H36O3SiNa: 
375.2326 [M+Na]+; found: 375.2328. 
Small amounts of a cyclic dimer were also isolated, which analyzed as follows: 1H NMR (400 MHz, 
CDCl3): δ = 4.31 (t, J = 6.4 Hz, 2H), 4.20-4.09 (m, 4H), 2.60-2.47 (m, 4H), 2.31 (t, J = 7.5 Hz, 4H), 1.70-
1.56 (m, 8H), 1.48-1.22 (m, 20H), 0.90 (s, 18H), 0.11 (s, 6H), 0.09 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 
= 173.6, 83.3, 80.4, 63.1, 62.2, 38.9, 34.4, 29.5, 29.4, 29.3, 29.2, 25.8, 25.2, 25.1, 19.3, 18.3, –4.5, –
5.0; MS (EI): m/z (%): 689 (2), 647 (100), 629 (1), 555 (1), 515 (4), 423 (3), 347 (6), 295 (20), 277 (5), 
243 (6), 185 (4), 93 (5), 73 (24), 55 (4); HRMS (ESI+): m/z: calcd for C40H72O6Si2Na: 727.4760 [M+Na]
+; 
found: 727.4757. 
Cycloalkyne 18b: Prepared analogously as a colorless syrup. 1H NMR (400 MHz, CDCl3): δ = 5.38-5.32 
(m, 1H), 4.14 (t, J = 5.2 Hz, 2H), 2.62-2.49 (m, 2H), 2.40-2.34 (m, 2H), 2.04 (s, 3H), 
1.75-1.60 (m, 4H), 1.54-1.20 (m, 10H); 13C NMR (100 MHz, CDCl3): δ = 174.1, 170.0, 
83.3, 78.4, 64.7, 62.9, 33.9, 33.2, 26.9, 26.8, 26.0, 25.7, 24.9, 22.5, 21.1, 19.2; IR 
(film): ν~  = 2931, 2860, 1735, 1458, 1372, 1350, 1233, 1178, 1104, 1020, 971 cm-1; 
MS (EI): m/z (%): 280 (9) [M]+, 238 (8), 220 (7), 192 (4), 179 (3), 163 (2), 151 (5), 137 
(16), 123 (14), 96 (100), 91 (19), 79 (18), 67 (15), 55 (39), 43 (94); HRMS (ESI+): m/z: calcd for 
C16H24O4Na: 303.1567 [M+Na]
+; found: 303.1566. 
Cycloalkyne 18c: Prepared analogously as a colorless oil.1H NMR (400 MHz, CDCl3): δ = 4.89 (d, J = 6.7 
Hz, 1H), 4.57 (d, J = 6.7 Hz, 1H), 4.39-4.30 (m, 1H), 4.20-4.07 (m, 2H), 3.35 (s, 3H), 
2.65-2.53 (m, 2H), 2.43-2.30 (m, 2H), 1.80-1.55 (m, 4H), 1.50-1.20 (m, 10H); 13C NMR 
(100 MHz, CDCl3): δ = 174.2, 94.0, 83.3, 79.5, 66.1, 63.0, 55.5, 34.8, 33.3, 27.0, 26.8, 
26.1, 25.7, 24.9, 22.7, 19.2; IR (film): ν~  = 2931, 2860, 1734, 1458, 1384, 1343, 1213, 
1149, 1100, 1033, 947, 919 cm-1; MS (EI): m/z (%): 282 (< 1) [M]+, 252 (1), 237 (2), 221 
(5), 169 (3), 151 (4), 139 (6), 126 (7), 107 (7), 96 (14), 80 (9), 67 (9), 55 (17), 45 (100), 41 (14); HRMS 
(ESI+): m/z: calcd for C16H26O4Na: 305.1723 [M+Na]
+; found: 305.1721. 
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Compound 18d (R = H). p-TsOH·H2O (5.7 mg, 0.030 mmol) was added to a solution of cycloalkyne 18a 
(13 mg, 0.037 mmol) in MeOH (1.5 mL). The resulting mixture was stirred for 40 min 
before the reaction was quenched with H2O.  The product was extracted with a 
mixture of hexanes and EtOAc and the organic layer was dried over Na2SO4 and 
evaporated. Purification of the residue by flash chromatography (hexane/EtOAc, 4:1) 
provided the title compound as a colorless oil (8.2 mg, 92%). 1H NMR (400 MHz, CDCl3): δ = 4.45-4.35 
(m, 1H), 4.21-4.08 (m, 2H), 2.66-2.52 (m, 2H), 2.44-2.30 (m, 2H), 1.78 (brs, 1H), 1.73-1.55 (m, 4H), 
1.50-1.20 (m, 10H); 13C NMR (100 MHz, CDCl3): δ = 174.1, 82.6, 82.0, 63.0, 62.9, 37.1, 33.4, 27.0, 26.8, 
26.1, 25.8, 24.9, 22.7, 19.2; IR (film): ṽ = 3421, 2931, 2859, 1733, 1457, 1385, 1340, 1232, 1176, 1100, 
1030 cm-1; MS (EI): m/z (%): 238 (< 1) [M]+, 220 (10), 209 (2), 191 (5), 181 (4), 163 (9), 149 (9), 137 
(12), 123 (23), 109 (25), 96 (75), 81 (100), 73 (15), 67 (28), 55 (87), 41 (70), 29 (24); HRMS (ESI+): m/z: 
calcd for C14H22O3Na: 261.1461 [M+Na]
+; found: 261.1459. 
Enone 20. Complex 19 (1.4 mg, 1.8 µmol) and 10-camphorsulfonic acid (0.7 mg, 3.0 µmol) were 
added to a solution of compound 18d (4.2 mg, 0.018 mmol) in THF (1.5 mL). The 
solution was stirred for 10 min before In(OTf)3 (1.0 mg, 1.8 µmol) was introduced and 
the resulting mixture stirred under reflux for 3 h.  After cooling to room temperature, 
the mixture was passed through a short plug of silica, the filtrate was evaporated, 
and the residue purified by flash chromatography (hexane/EtOAc, 4:1) to provide 
enone 20 as a colorless oil (3.3 mg, 79%). 1H NMR (400 MHz, CDCl3): δ = 6.76 (dt, J = 15.8, 6.8 Hz, 1H), 
6.22 (d, J = 15.8 Hz, 1H), 4.27 (t, J = 5.4 Hz, 2H), 2.62-2.55 (m, 2H), 2.48 (t, J = 6.8 Hz, 2H), 2.34-2.29 
(m, 2H), 1.70-1.55 (m, 4H), 1.40-1.16 (m, 8H); 13C NMR (100 MHz, CDCl3): δ = 201.7, 173.9, 143.6, 
131.6, 62.3, 40.4, 34.0, 31.7, 27.1, 26.9, 26.6, 26.4, 24.9, 24.6; IR (film): ṽ = 2932, 2856, 1732, 1694, 
1668, 1629, 1459, 1348, 1255, 1169, 1052, 977 cm-1; MS (EI): m/z (%): 238 (23) [M]+, 220 (3), 210 (2), 
192 (3), 180 (2), 165 (1), 151 (2), 137 (8), 124 (38), 109 (9), 96 (100), 84 (17), 81 (75), 69 (9), 55 (44), 
41 (34), 29 (10); HRMS (ESI+): m/z: calcd for C14H22O3Na: 261.1461 [M+Na]
+; found: 261.1461. 
 
 
Scheme S1. Preparation of compound 21: a) 6-(Tri-isopropylsilyloxy)hexylmagnesium bromide, THF, 
78°C, 55%; b) PMBOC(=NH)CCl3, Sc(OTf)3 (10 mol%), toluene, 64%; c) K2CO3, MeOH, 71%; d) Dess-
Martin periodinane, CH2Cl2, 72%; e) propynylmagnesium bromide, THF, 75%; f) Ac2O, Et3N, DMAP (10 
mol%), CH2Cl2, 89%; g) trifluoromethansulfonic acid, aq. THF, 90%; h) 5-hexynoic acid, DCC, DMAP (5 
mol%), CH2Cl2, 0°C  RT, 71%; DCC = dicyclohexylcarbodiimide; DMAP = 4-dimethylaminopyridine; 
PMP = p-methoxybenzyl; Tf = trifluoromethanesulfonyl 
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Compound 21. DCC (105 mg, 0.517 mmol) was added to a solution of 5-heptynoic acid (65 mg, 0.517 
mmol), 14-hydroxy-8-((4-methoxybenzyl)oxy)tetradec-2-yn-4-yl acetate (190 mg, 
0.47 mmol) and DMAP (5.7 mg, 0,047 mmol) in CH2Cl2 (4.7 mL) at 0°C. The mixture 
was stirred at room temperature for 5 hours before the precipitated urea was 
filtered off and the filtrate was evaporated. The residue was dissolved in CH2Cl2 (4 
mL) and the resulting solution washed with HCl (0.5 M, 2 x 2 mL) and aq. sat. 
NaHCO3 (2 x 2 mL). After drying over Na2SO4, the solvent was evaporated and the 
residue purified by flash chromatography (hexane/EtOAc, 15:1  10:1) to yield the 
title compound as a colorless oil (170 mg, 71%, mixture of diastereomers).  1H NMR (400 MHz, CDCl3): 
δ = 7.25 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 5.34-5.29 (m, 1H), 4.42 (s, 2H), 4.05 (t, J = 6.7 Hz, 
2H), 3.79 (s, 3H), 3.37-3.32 (m, 1H), 2.41 (t, J = 7.5 Hz, 2H), 2.21-2.16 (m, 2H), 2.06 (s, 3H), 1.83 (d, J = 
2.1 Hz, 3H), 1.83-1.21 (m, 21 H); 13C NMR (100 MHz, CDCl3, resolved signals of diastereomers): δ 
=173.6, 170.3, 159.3, 131.3, 129.5, 129.5, 113.9, 81.9, 78.5, 78.4, 78.2, 77.0, 76.6, 70.7, 64.7, 64.6, 
55.5, 35.3, 35.3, 34.0, 34.0, 33.6, 33.5, 33.4, 29.7, 28.8, 26.1, 25.5, 25.4, 24.5, 21.3, 21.1, 21.1, 18.4. 
3.8, 3.6; IR (film): ṽ = 2935, 2859, 1735, 1612, 1513, 1457, 1370, 1302, 1237, 1171, 1034, 819 cm-1; 
MS (EI) m/z (%): 452 (4.97), 391 (0.47), 121 (100); HRMS (ESI): m/z: calcd. for C31H44NaO6 [M
++Na]: 
535.3030, found: 535.3037  
Compound 22. Powdered molecular sieves (MS 5Å, 120 mg) was added to a solution of compound 21 
(120 mg, 0.234 mmol) in toluene (115 mL),  and the resulting mixture was 
stirred at 80 °C for 15 min. Catalyst 1 (Ar = pMeOC6H4-) (26 mg, 0.0234 mmol) 
was introduced and stirring continued at 80 °C for 15 h. To ensure total 
conversion, additional catalyst 1 (Ar = pMeOC6H4-) (5.2 mg, 0.0047 mmol) was 
added and the mixture stirred for an additional hour at the same temperature. 
The mixture was filtrated through a pad of silica which was rinsed with ethyl acetate. The combined 
filtrates were evaporated and the residue was purified by flash chromatography (hexane/EtOAc, 
10:1) to yield the title compound as a viscous oil (100 mg, 95%, mixture of diastereomers). 1H NMR 
(400 MHz, CDCl3): δ = 7.25 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 5.40-5.36 (m, 1H), 4.70 (d, J = 
11.3 Hz, 1H), 4.37 (d, J = 11.3 Hz, 1H), 4.18-4.06 (m, 2H), 3.80 (s, 3H), 3.39-3.30 (m, 1H), 2.40-2.39 (m, 
2H), 2.28 (dt, J = 7.2, 1.9 Hz, 2H), 2.07 (d, J = 1.3, 3H), 1.85 (quint, J = 7.5, 2H), 1.72-1.25 (m, 16H); 13C 
NMR (100 MHz, CDCl3, resolved signals of diastereomers): δ = 173.1, 170.2, 170.1, 159.3, 131.3, 
129.4, 129.4, 113.9, 85.7, 85.7, 70.5, 70.4, 64.8, 64.7, 64.3, 55.5, 34.9, 34.8, 33.9, 33.8, 32.9, 32.8, 
32.5, 32.5, 28.1, 28.0, 25.2, 24.6, 24.5, 24.5, 21.4, 20.6, 20.4, 18.5; IR (film): ṽ = 2934, 2858, 1734, 
1513, 1238, 1096 cm-1; MS (EI) m/z (%): 398 (6.25), 337 (0.72), 121 (100); HRMS (ESI): m/z: calcd. for 
C27H38NaO6 [M
++Na]: 481.2571, found: 481.2563.  
Compound 22b. 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (513 mg, 1.05 
mmol) was added to a solution of compound 22a (100 mg, 0.21 mmol) in a 
biphasic mixture CH2Cl2 (20 mL) and phosphate buffer (pH 7, 20 mL). The mixture 
was stirred for 70 min before it was diluted with CH2Cl2 (20 mL). The organic 
layer was washed with sat. aq. NaHCO3 (2 x 50 mL), the aqueous phase was 
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extracted with CH2Cl2 (3 x 20 mL), the combined organic layers were dried over Na2SO4 and 
evaporated. The residue was purified by flash chromatography (hexane/EtOAc, 3:1) to yield the 
corresponding alcohol as a colorless syrup (69 mg, 97%, mixture of diastereomers). 1H NMR (400 
MHz, CDCl3): δ = 5.41-5.35 (m, 1H), 4.18-4.07 (m, 2H), 3.67-3.65 (m, 1H), 2.42 (dt, J = 8.0, 1.6 Hz, 2H), 
2.29 (dt, J = 7.12, 2.16 Hz, 2H), 2.06 (s, 3H), 1.85 (quint, J = 7.4 Hz, 2H), 1.75-1.35 (m, 16H), 1.24 (bs, 
1H); 13C NMR (100 MHz, CDCl3, resolved ignals of diastereomers): δ = 173.1, 170.2, 170.1, 85.8, 85.7, 
78.4, 78.3, 71.4, 71.3, 64.7, 64.6, 64.3, 64.2, 37.2, 37.2, 34.8, 34.8, 34.6, 33.8, 33.7, 28.0, 27.9, 26.7, 
27.6, 25.0, 24.4, 24.3, 24.2, 21.3, 21.3, 20.8, 20.518.5, 18.4; IR (film): ṽ = 3466, 2934, 2860, 1734, 
1458, 1372, 1234, 1167, 1020 cm-1; MS (EI) m/z (%): 296 (11.3), 278 (8.89), 43 (100); HRMS (ESI): m/z: 
calcd. for C19H30NaO5 [M
++Na]: 361.1985, found: 361.1981.  
Compound 24. Ph3PAuNTf2 (14 µL of a 0.05 M stock solution in CH2Cl2, 0.0007 mmol) was added to a 
solution of compound 22b (5 mg, 0.0147 mmol) in CH2Cl2 (0.7 mL). The mixture 
was stirred for 1 hour 45 minutes before it was filtered through a pad of Celite. 
The filtrate was evaporated and the residue purified by flash chromatography 
(hexane/EtOAc, 10:1) to yield the title compound as a viscous oil (4.5 mg, 95%). 1H 
NMR (600 MHz, CDCl3): δ = 5.22 (d, J = 8.2 Hz, 1H), 4.44 (dt, J = 11.2, 3.1 Hz, 1H), 
3.94-3.88 (m, 2H), 3.40-3.34 (m, 1H), 2.49 (ddd, J = 14.7, 8.7, 7.8 Hz, 1H), 2.43-2.28 (m, 3H), 2.11 (s, 
3H), 1.88-1.17 (m, 18H); 13C NMR (150 MHz, CDCl3): δ = 173.9, 169.5, 151.7, 120.5, 75.6, 73.6, 62.7, 
35.5, 33.1, 32.2, 31.9, 28.9, 27.3, 25.9, 25.2, 24.7, 23.8, 22.1, 21.2; IR (film): ṽ = 2932, 2838, 1765, 
1732, 1368, 12100, 1074, 1024, 910  cm-1; MS (EI) m/z (%): 296 (17.5), 279 (39.75), 43 (100); HRMS 
(ESI): m/z: calcd. for C19H30NaO5 [M
++Na]: 361.1985, found: 361.1982.  
Compound 25. Ph3PAuNTf2 (47 µL from a 0.05 M stock solution in CH2Cl2, 0.00235 mmol) was added 
to a solution of compound 22b (16 mg, 0.047 mmol) in CH2Cl2 (2.1 ml). The mixture 
was stirred for 90 min before K2CO3 (19.5 mg, 0.141 mmol) and MeOH (1 mL) were 
introduced. After stirring for additional 45 minutes, the mixture was washed with 
sat. aq. NH4Cl (2 mL) and extracted with CH2Cl2 (2 x 2 mL). The combined extracts 
were dried over Na2SO4 and evaporated, and the residue was purified by flash 
chromatography (hexane/EtOAc, 9:1) to yield the title compound as a white solid (10. 8 mg, 78%). 1H 
NMR (400 MHz, CDCl3): δ = 4.41-4.1 (m, 2H), 3.73 (tt,  J = 10.8, 4.4 Hz, 1H), 3.28-3.23 (m, 1H), 2.64-
2.48 (m, 3H), 2.38 (7, J = 6.2 Hz, 2H), 7.42 (dd, J = 13.8, 2.5 Hz, 1H), 1.94-1.11 (m, 18H). 13C NMR (100 
MHz, CDCl3): δ = 209.9, 173.7, 77.2, 75.5, 63.2, 50.2, 42.2, 35.7, 33.9, 31.9, 31.7, 27.7, 27.1, 25.2, 
25.0, 23.8, 18.9; IR (film): ṽ = 2924, 2854, 1733, 1458, 1375, 1254, 1200, 1157, 1081, 1013, 721 cm-1; 
MS (EI) m/z (%): 115 (77.3), 41 (100); HRMS (ESI): m/z: calcd. for C17H28NaO4 [M
++Na]: 319.1879, 
found: 319.1881. 
11-Tridecynyl but-2-ynoate (48a). Triphenylphosphine (786 mg, 3 mmol) and 
diisopropyl azodicarboxylate (0.6 mL, 3 mmol) were successively added to a 
solution of 11-tridecyn-1-ol (300 mg, 1.5 mmol) and 2-butynoic acid (193 mg, 3 
mmol) in toluene (20 mL) at 0°C. The ice bath was removed and the solution stirred 
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at room temperature for 1.5 h. For work up, the solvent was evaporated and the residue was purified 
by flash chromatography (hexane/EtOAc, 40:1  30:1) to afford the title compound as a colorless oil 
(361 mg, 92%). 1H NMR (400 MHz, CDCl3): δ = 4.14 (t, J = 6.8 Hz 2H), 2.11 (tq, J = 7.0, 2.6 Hz, 2H), 1.98 
(s, 3H), 1.78 (t, J = 2.6 Hz, 3H), 1.65 (quint, J = 6.8 Hz, 2H), 1.46 (quint, J = 7.0 Hz, 2H), 1.38-1.25 (m, 
12H); 13C NMR (100 MHz, CDCl3): δ = 154.1, 85.5, 79.6, 75.5, 72.8, 66.2, 29.6, 29.4, 29.4, 29.3, 29.1, 
28.6, 26.0, 19.0, 4.0, 3.7; IR (film): ṽ = 2924, 2855, 2243, 1708, 1248, 1073, 751 cm-1; MS (EI) m/z (%): 
137 (16), 135 (11), 121 (14), 111 (11), 109 (12), 108 (11) 107 (23), 96 (10), 95 (38), 94 (19), 93 (38), 85 
(33), 82 (15), 81 (43), 80 (15), 79 (39), 69 (26), 68 (57), 67 (100), 66 (13); 55 (47), 54 (17), 53 (20), 43 
(14), 41 (43), 39 (22), 29 (11); HRMS (ESI): m/z: calcd. for C17H26O2Na [M
++Na]: 285.1822, found 
285.1825.  
15-Heptadecynyl but-2-ynoate (48b). Prepared analogously as a white solid (361 mg, 88%). Mp 43.8-
44.5 °C. 1H NMR (400 MHz, CDCl3): δ = 4.12 (t, J = 6.8 Hz, 2H), 2.11-2.05 (m, 2H), 
1.97 (s, 3H), 1.75 (t, J = 2.4 Hz, 3H), 1.64 (quint, J = 7.6 Hz, 2H), 1.48-1.22 (m, 
22H); 13C NMR (100 MHz, CDCl3): δ = 154.0, 85.4, 79.6, 75.4, 72.7, 66.1, 29.8, 
29.7, 29.6, 29.4, 29.3, 29.1, 28.9, 28.6, 28.4, 26.0, 21.8, 18.9, 3.9, 3.6; IR (film): ṽ 
= 2915, 2847, 2242, 1703, 1460, 1260, 1076, 754, 724 cm-1; MS (EI) m/z (%): 
318 (1), 151 (17), 139 (12), 138 (21), 137 (26), 135 (15), 124 (13), 121 (21), 109 
(30), 108 (17), 107 (28), 97 (16), 96 (21), 95 (74), 94 (24), 93 ( 37), 85 (51), 83 
(22), 82 (23), 81 (61), 80 (18), 79 (32), 69 (38), 68 (82), 67 (100), 66 (10), 57 (11), 
55 (73), 84 (23), 53 (19), 43 (26), 41 (52), 39 (17), 29 (12); HRMS (ESI): m/z: calcd. for C21H34O2Na 
[M++Na]: 341.2451, found 341.2451.  
Representative Procedure for the RCAM of Alkynoates. Preparation of Compound 49a. A mixture 
comprising compound 48a (20 mg, 0.07 mmol) and powdered molecular sieves (MS 5 Å, 400 mg) in 
toluene (70 mL) was stirred at ambient temperature for 30 min before complex 1 (5 
mg, 0.0004 mmol) was added. The mixture was stirred at 80 °C for 2 h, cooled to 
ambient temperature, filtered through a plug of silica gel that was carefully rinsed 
with hexane:ethyl acetate (1:1). The combined filtrates were evaporated and the residue was 
purified by flash chromatography (hexane/EtOAc, 50:1  30:1) to give product 49a as a colorless oil 
(10 mg, 66%), which analysed as follows: 1H NMR (300 MHz, CDCl3): δ = 4.17 (t, J = 6.2 Hz, 2H), 2.36 
(t, J = 6.6 Hz, 2H), 1.67 (tt, J = 6.6, 6.0 Hz, 2H), 1.61-1.54 (m, 2H), 1.49-1.29 ppm (m, 12H); 13C NMR 
(100 MHz, CDCl3): δ = 154.3, 89.7, 73.7, 66.1, 29.2, 29.2, 29.1, 29.0, 28.6, 28.4, 27.4, 26.0, 18.8 ppm; 
IR (film): ṽ = 2922, 2852, 2232, 1712, 1254, 1080, 753 cm-1; MS (EI) m/z (%): 208 (5), 149 (10), 136 
(12), 135 (27), 123 (12), 122 (23), 121 (43), 119 (13), 109 (12), 108 (29), 107 (47), 105 (12), 97 (18), 95 
(31), 94 (25), 93 (51), 91 (24), 82 (19), 81 (67), 80 (25), 79 (100), 77 (20), 71 (12), 69 (16), 68 (77), 67 
(53), 66 (49), 55 (66), 54 (10), 53 (27), 43 (22), 41 (78), 39 (33), 29 (19), 27 (18); HRMS (ESI): m/z: 
calcd. for C13H20O2Na [M




In addition, a small amount of a second product was isolated as a white solid, which turned out to be 
the corresponding cyclic dimer (3.8 mg, 23%). 1H NMR (400 MHz, CDCl3): δ = 
4.17 (t, J = 6.2 Hz, 4H), 2.36 (t, J = 6.7 Hz, 4H), 1.67 (tt, J = 6.7, 6.2 Hz, 4H), 1.61-
1.55 (m, 4H), 1.47-1.29 (m, 24H) ppm; 13C NMR (100 MHz, CDCl3): δ = 154.3, 
89.7, 73.6, 66.1, 29.2, 29.2, 29.1, 29.0, 28.6, 28.4, 27.4, 26.0, 18.8 ppm; IR 
(film): ṽ = 2922, 2852, 2236, 1718, 1253, 1079, 753 cm-1; MS (EI) m/z (%): 417 (5), 416 (16), 227 (15), 
191 (19), 190 (27), 163 (17), 162 (17), 161 (15), 149 (18), 148 (16), 147 (20), 135 (19), 133 (19), 122 
(31), 119 (21), 109 (15), 108 (18), 107 (35), 105 (22), 95 (36), 94 (21), 93 (56), 91 (37), 83 (16), 81 (62), 
80 (23), 79 (81), 77 (27), 69 (53), 97 (95), 57 (16), 53 (26), 52 (16), 44 (28), 43 (49), 41 (86), 29 (24); 
HRMS (ESI): m/z: calcd. for C26H40O4Na [M
++Na]: 439.2818, found 439.2819. See Figure S2 for a 
confirmation of this assignment by X-ray diffraction. 
Compound 49b. Prepared analogously as a white solid (36 mg, 92%).  1H NMR (300 MHz, CDCl3): δ = 
4.21 (t, J = 5.3 Hz, 2H), 2.38 (t, J = 5.9 Hz, 2H), 1.66-1.60 (m, 2H), 1.53-1.23 ppm (m, 22H); 13C NMR 
(100 MHz, CDCl3): δ = 154.3, 89.2, 74.1, 65.8, 28.7, 28.3, 28.2, 27.8, 27.3, 27.1, 
26.9, 26.8, 26.6, 24.5, 18.6 ppm; IR (film): ṽ = 2925, 2856, 2235, 1711, 1460, 
1244, 1078, 751cm-1; MS (EI) m/z (%): 264 (3), 165 (28), 140 (27), 138 (39), 126 
(26), 124 (26), 121 (27), 109 (23), 107 (28), 95 (49), 94 (26), 93 (46), 86 (21), 83 
(27), 82 (28), 81 (67), 80 (32), 79 (54), 69 (46), 68 (24), 67 (67), 66 (29), 55 (100), 53 (20), 43 (40), 41 
(100), 29 (31); HRMS (ESI): m/z: calcd. for C17H28O2Na [M
++Na]: 287.1983, found 287.1982.  
 
 
Scheme S2. Preparation of compound 50 
 
Compound S2. ((10-Bromodecyl)oxy)(tert-butyl)dimethylsilane (780 mg, 2.2 mmol) was dropwise 
added to a suspension of pre-activated magnesium (264 mg, 11 mmol, activated 
2 times on treatment with dichloroethane, 40 µL) in THF (5 mL). The suspension 
was stirred for 1 h at ambient temperature before it was added to a solution of 
5-heptynal (200 mg, 1.8 mmol) in THF (5 mL) at 0°C. The mixture was slowly 
warmed to room temperature and stirred 1 h before the reaction was 
quenched with sat. aq. NH4Cl and Et2O. The aqueous phase was extracted with Et2O (3x), the 
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combined organic layers were washed with brine and dried over Na2SO4, all volatile materials were 
evaporated and the residue was purified by flash chromatography (hexane/EtOAc, 9:1) to afford the 
title compound as a colorless oil (600 mg, 87%). 1H NMR (400 MHz, CDCl3): δ = 3.61-3.56 (m, 2H, 
overlap), 3.57 (t, J = 6.3 Hz, 2H, overlap), 2.16-2.11 (m, 2H), 1.75 (t, J = 2.5 Hz, 3H), 1.58-1.39 (m, 
10H), 1.30-1.23 (m, 14H), 0.87 (s, 9H), 0.02 (s, 6H). 13C NMR (100 MHz, CDCl3): δ = 79.2, 75.9, 71.7, 
63.5, 37.7, 36.7, 33.0, 29.9, 29.8, 29.7, 29.6, 26.0, 25.9, 25.8, 25.3, 18.9, 15.5, 3.6, 5.1; IR (film): ṽ = 
3339, 2926, 2854, 1462, 1387, 1361, 1254, 1097, 833, 773 cm-1; MS (EI) m/z (%): 325 (24), 135 (17), 
123 (11), 121 (15), 111 (13), 109 (41), 107 (17), 95 (100), 93 (21), 81 (53), 79 (10), 75 (65), 73 (14), 67 
(30); HRMS (ESI): m/z: calcd. for C23H46O2SiNa [M
++Na]: 405.3162, found: 305.3159.  
Compound S3. Pyridine (253 µL, 3.1 mmol) and TBSOTf (434 µL, 2.4 mmol) were successively added 
to a solution of the above alcohol (600 mg, 1.87 mmol) in dichloromethane (4 
mL) at 0°C. After 10 min, the mixture was warmed at room temperature and 
stirred for 1 h before dichloromethane and sat. aq. NH4Cl were added. The 
aqueous phase was extracted with Et2O (3x), the combined organic layers were 
dried over Na2SO4 and evaporated, and the residue was purified by flash 
chromatography (hexane/EtOAc, 30:1) to afford the title compound as a colorless oil (544 mg, 99%). 
1H NMR (400 MHz, CDCl3): δ = 3.69-3.62 (m, 1H, overlap), 3.60 (t, J = 6.6 Hz, 2H, overlap), 2.15-2.09 
(m, 2H), 1.77 (t, J = 2.5 Hz, 3H), 1.55-1.24 (m, 24H), 0.90 (s, 9H), 0.89 (s, 9H), 0.05 (s, 12H). 13C NMR 
(100 MHz, CDCl3): δ = 79.5, 75.7, 72.2, 63.6, 37.3, 36.4, 33.1, 30.1, 29.8, 29.8, 29.7, 26.2, 26.2, 26.0, 
25.6, 25.0, 19.1, 3.6, 4.2, 5.1; IR (film): ṽ = 2927, 2855, 1471, 1462, 1253, 1097, 832, 772 cm-1; MS 
(EI) m/z (%): 440 (14), 439 (38), 307 (11), 233 (13), 191 (15), 149 (20), 147 (20), 135 (19), 121 (16), 
109 (16), 107 (13), 95 (41), 93 (39), 81 (19), 75 (100), 73 (36), 67 (10); HRMS (ESI): m/z: calcd. for 
C29H60O2Si2Na[M
++Na]: 519.4023, found: 519.4024.  
Compound S4. p-TsOH (5.5 mg, 0.029 mmol) was added to a solution of compound S3 (290 mg, 0.58 
mmol) in CH2Cl2/MeOH (1:1, 6 mL) at 0°C. After stirring for 45 min at that 
temperature, the reaction was quenched with sat. aq. NaHCO3, the aqueous 
phase was extracted three times with ethyl acetate, the combined extracts 
were dried over Na2SO4 and evaporated. Purification of the residue by flash 
chromatography (hexane/EtOAc, 15:1) afforded the title compound as a 
colorless oil (161 mg, 80%). 1H NMR (400 MHz, CDCl3): δ = 3.67-3.54 (m, 1H, overlap), 3.63 (t, J = 6.6 
Hz, 2H, overlap), 2.13-2.09 (m, 2H), 1.77 (t, J = 2.5 Hz, 3H), 1.60-1.24 (m, 25H), 0.88 (s, 9H), 0.04 (2, 
3H), 0.03 (s, 3H). 13C NMR (100 MHz, CDCl3): δ = 79.5, 75.7, 72.2, 63.3, 37.3, 36.4, 33.0, 30.0, 29.8, 
29.8, 29.8, 29.6, 26.2, 26.0, 25.5, 25.0, 19.1, 18.4, 3.7, 4.2; IR (film): ṽ = 3347, 2926, 2854, 1462, 
1373, 1360, 1253, 1057, 1005, 834, 772 cm-1; MS (EI) m/z (%): 325 (12), 301 (11), 149 (10), 135 (18), 
123 (12), 121 (16), 109 (39), 107 (18), 95 (98), 93 (43), 109 (39), 107 (18), 95 (98), 93 (43), 83 (11), 81 
(53), 75 (100), 73 (44), 69 (18), 67 (23), 55 (21); HRMS (ESI): m/z: calcd. for C23H46O2SiNa [M
++Na]: 




Compound 50. Ph3P (46 mg, 0.18 mmol) and DIAD (35 µL, 0.178 mmol) were added to a solution of 
alcohol S4 (60 mg, 0.16 mmol) and 2-butynoic acid (21 mg, 0.24 mmol) in 
toluene (8 mL) at 0°C. The reaction was stirred at room temperature for 1 h 
before the solvent was evaporated. The residue was purified by flash 
chromatography (hexane/EtOAc, 30:1) to afford product 50 as a colorless oil (65 
mg, 91%). 1H NMR (300 MHz, CDCl3): δ = 4.14 (t, J = 6.8 Hz, 2H), 3.69-3.62 (m, 
1H), 2.15-2.08 (m, 2H), 1.98 (s, 3H), 1.77 (s, J = 2.6 Hz, 3H), 1.66 (quint., J = 6.9 Hz, 2H), 1.59-1.21 (m, 
22H), 0.89 (s, 9H), 0.04 (s, 3H), 0.04 (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 154.1, 85.4, 79.4,  75.7, 
72.8, 72.2, 66.2, 37.3, 36.4, 30.0, 29.8, 29.7, 29.7, 29.4, 28.6, 26.1, 26.0, 25.5, 25.0, 19.1, 18.4, 4.0, 
3.6, 4.2; IR (film): ṽ = 2927, 2855, 2244, 1712, 1463, 1253, 1072, 835, 773 cm-1; MS (EI) m/z (%): 392 
(24), 391 (72), 367 (14), 159 (23), 149 (11), 142 (15), 141 (100), 97 (14), 95 (41), 93 (21), 81 (21), 75 
(58), 73 (28), 69 (12), 67 (24), 55 (15); HRMS (ESI): m/z: calcd. for C27H48O3SiNa [M
++Na]: 471.3265, 
found: 471.3269.  
Compound 51. A solution of compound 50 (60 mg, 0.13 mmol) containing powdered molecular 
sieves (MS 5 Å, 800 mg) in toluene (130 mL) was stirred at ambient temperature 
for 30 min before complex 1 (9 mg, 0.007 mmol) was added. The mixture was 
stirred at 80 °C for 2 h before it was passed through a short pad of silica that was 
carefully rinsed with hexane/ethyl acetate (1:1). The filtrate was evaporated and 
the residue purified by flash chromatography (hexane/EtOAc, 40:1  30:1) to afford the title 
compound as a colorless oil (41 mg, 84%). 1H NMR (400 MHz, CDCl3): δ = 4.20 (t, J = 5.3 Hz, 2H), 3.71-
3.65 (m, 1H), 2.41-2.35 (m, 2H), 1.80-1.25 (m, 22H), 0.87 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H). 13C NMR 
(100 MHz, CDCl3): δ = 154.2, 88.1, 74.1, 71.9, 65.8, 37.7, 34.4, 29.3, 28.5, 28.1, 27.6, 27.0, 26.3, 26.1, 
24.5, 24.2, 23.1, 18.7, 18.3, 4.1, 4.5; IR (film): ṽ = 2929, 2856, 2236, 1713, 1462, 1247, 1081, 835, 
774 cm-1; MS (EI) m/z (%): 338 (26), 337 (100), 319 (42), 79 (10), 75 (40), 73 (21), 55 (10); HRMS (ESI): 
m/z: calcd. for C23H42O3SiNa [M
++Na]: 417.2798, found: 417.2795.  
Compound 52. p-TsOH (2 mg, 0.01 mmol) was added to a solution of compound 51 (39 mg, 0.1 
mmol) in MeOH (1 mL) at 0°C and the resulting mixture stirred at ambient 
temperature for 2 h before it was quenched with sat. aq. NaHCO3. The methanol 
was partially removed under vacuum, the residue was extracted three times 
with ethyl acetate. The combined extracts were dried over Na2SO4 and 
evaporated and the residue was purified by flash chromatography 
(hexanes/EtOAc, 8:1) to afford the title compound as a colorless oil (21 mg, 85%). 1H NMR (400 MHz, 
CDCl3): δ = 4.21 (t, J = 5.4 Hz, 2H), 3.75-3.66 (m, 1H), 2.48 (ddd, J = 17.5, 8.1, 4.3 Hz, 1H), 2.38 (ddd, J 
= 17.5, 8.1, 4.2 Hz, 1H), 1.92-1.84 (m, 1H), 1.81-1.71 (m, 1H), 1.67-1.55 (m, 4H), 1.50-2.28 (m, 16H), 
1.24 (br s, 1H). 13C NMR (100 MHz, CDCl3): δ = 154.4, 88.7, 74.3, 71.1, 65.9, 37.7, 34.1, 28.9, 28.2, 
28.1, 27.6, 27.0, 26.3, 24.4, 24.3, 22.9, 18.4; IR (film): ṽ = 3404, 2930, 2870, 2236, 1712, 1250, 1080 
cm-1; MS (EI) m/z (%): 280 (2), 141 (20), 123 (100), 122 (31), 113 (53), 95 (52), 84 (40), 83 (28), 81 
(36), 79 (32), 69 (42), 68 (25), 67 (42), 66 (49), 55 (78), 43 (36), 41 (74), 26 (26); HRMS (ESI): m/z: 
calcd. for C17H28O3Na [M
++Na]: 303.1929, found: 303.1931.  
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Compound 53. A freshly prepared solution of AuCl3 in anhydrous MeOH (0.01 M, 150 µL, 2 mol%) was 
added to compound 52 (21 mg, 0.075 mmol) at 0°C. The mixture was stirred at 
ambient temperature for 40 min before it was diluted with pentane/Et2O (4:1) 
and sat. aq. NaHCO3. The aqueous phase was extracted with Et2O and the 
combined organic layers were washed with water, brine and dried over Na2SO4. 
The solvent was evaporated and the residue purified by flash chromatography (pentane/Et2O, 8:1; 
the silica was deactivated with pentane/Et2O/NEt3, 8:2:1 prior to use) to afford the title compound as 
a colorless oil (22 mg, 96%). 1H NMR (400 MHz, CDCl3): δ = 4.43 (ddd, J = 10.7, 6.3, 4.5 Hz, 1H), 3.80 
(ddd, J = 10.7, 6.6, 4.1 Hz, 1H), 3.47 (ddt, J = 11.5, 9.3, 2.2 Hz, 1H), 3.22 (s, 3H), 2.92 (d, J = 12.9 Hz, 
1H), 2.18 (d, J = 12.9 Hz, 1H), 2.11 (td, J = 13.0, 4.6 Hz, 1H), 1.86-1.69 (m, 2H), 1.62-1.15 (m, 21H). 13C 
NMR (100 MHz, CDCl3): δ = 170.6, 98.4, 71.4, 64.6, 47.7, 42.2, 35.6, 32.1, 30.8, 28.4, 27.3, 26.9, 26.4, 
25.8, 24.3, 24.1, 23.1, 19.2; IR (film): ṽ = 2932, 2860, 1734, 1459, 1384, 1350, 1326, 1228, 1209, 1098, 
1054, 1043, 1021, 964, 947, 851 cm-1; MS (EI) m/z (%): 312 (5), 281 (24), 194 (32), 166 (13), 119 (100), 
117 (15), 116 (14), 110 (14), 109 (11), 101 (17), 96 (25), 95 (17), 83 (13), 82 (29), 81 (22), 69 (17), 68 
(16), 67 (20), 55 (30), 54 (12), 43 (14), 41 (31); HRMS (ESI): m/z: calcd. for C18H32O4Na [M
++Na]: 
325.2194, found: 325.2193. 
Representative Procedure for Alkyne Dimerization. Preparation of 1,2-Bis(dimethyl(phenyl)-
silyl)ethyne: A suspension containing dimethyl(phenyl)(prop-1-yn-1-yl)silane (174 mg, 1 mmol), 
complex 1 (21 mg, 0.02 mmol, 2 mol%) and powdered MS 5Å (2 g) in toluene (5 mL) was stirred for 2 
h at ambient temperature. The mixture was then filtered through a pad of silica, the filtrate was 
evaporated, and the residue purified by flash chromatography (pentane/EtOAc, 98:2) to give the title 
compound as a colorless oil (137 mg, 93%). 1H NMR (400 MHz, CDCl3): δ = 7.72-7.70 (m, 4H), 7.44-
7.40 (m, 6H), 0.50 (m, 12H) ; 13C NMR (100 MHz, CDCl3): δ = 136.9 (2C), 133.9 (4C), 129.6 (2C), 128.0 
(4C), 113.8 (2C), 0.7 (4C); IR (film): ṽ = 3069, 3050, 3021, 2960, 1606, 1508, 1428, 1249, 1113, 825, 
779 cm-1; MS (EI) m/z (%): 294 (35) [M+], 279 (100), 221 (18), 135 (29), 105 (14); HRMS (ESI): m/z: 
calcd. for C18H22Si2: 294.1260; found: 294.1259. The analytical and spectroscopic data are in 
agreement with those reported in the literature.3 
1,2-Bis(diphenylphosphino)ethyne. Prepared analogously as a colorless solid (103 mg, 52%). Mp = 
71-73 °C; 1H NMR (400 MHz, CDCl3): δ = 7.67-7.60 (m, 8H), 7.38-7.33 (m, 12H); 
13C NMR (100 MHz, CDCl3): δ = 135.8 (m, 4C), 132.8 (m, 8C), 129.3 (4C), 128.8 
(m, 8C), 107.0 (m, 4C); 31P NMR (162 MHz, CDCl3) ): δ = 31.1; IR (film): ṽ = 3055, 1585, 1571, 1478, 
1432, 1308, 1090, 1067, 1025, 998, 814, cm-1; MS (EI) m/z (%): 394 (100) [M+], 209 (87), 185 (48), 183 
(52), 165 (11), 107 (10), 77 (8); HRMS (ESI): m/z: calcd. for C26H20P2: 394.1040; found: 394.1042. The 
analytical and spectroscopic data are in agreement with those reported in the literature.4 
 
                                                 
3
  A. Naka, M. Ishikawa Organometallics 2000, 19, 4921-4924. 
4
  O. Ekkert, G. Kehr, R. Fröhlich, G. Erker J. Am. Chem. Soc. 2011, 133, 4610-4616.  
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Representative Procedure for Alkyne Cross Metathesis. Preparation of Hex-1-yn-1-
yldimethyl(phenyl)silane: A suspension containing dimethyl(phenyl)(prop-1-yn-1-yl)silane (174 mg, 1 
mmol), 5-decyne (270 μL, 1.5 mmol), complex 1 (21 mg, 0.02 mmol, 2 mol%) and powdered MS 5Å (1 
g) in toluene (5 mL) was stirred for 2h at ambient temperature. The mixture was then filtered 
through a pad of silica, the filtrate was evaporated, and the residue purified by flash chromatography 
(pentane) to give the title compound as a colorless oil (154 mg, 71%). 1H NMR (400 MHz, CDCl3): δ = 
7.65-7.61 (m, 2H), 7.39-7.36 (m, 3H), 2.29 (t, J = 7.1 Hz, 2H), 1.60-1.50 (m, 2H), 1.50-1.39 (m, 2H), 
0.93 (t, J = 7.3 Hz, 3H), 0.40 (s, 6H); 13C NMR (100 MHz, CDCl3): δ = 137.9, 133.8 (2C), 129.3, 127.9 
(2C), 109.8, 82.3, 30.8, 22.1, 19.8, 13.7, 0.4; IR (film): ṽ = 3069, 2958, 2932, 2873, 2173, 1428, 1248, 
1114, 834, 825, 778 cm-1; MS (EI) m/z (%): 216 (5) [M+], 201 (100), 174 (19), 159 (9), 145 (11), 105 (7), 
43 (8); HRMS (ESI): m/z: calcd. for C14H20Si: 216.1334; found: 216.1333. 
Hex-1-yn-1-yldiphenylphosphine. Prepared analogously as a pale yellow oil, (210 mg, 79%); 1H NMR 
(400 MHz, CDCl3): δ = 7.70-7.63 (m, 4H), 7.42-7.31 (m, 6H), 2.49 (dt, J = 7.1, 1.4 
Hz, 2H), 1.71-1.60 (m, 2H), 1.57-1.47 (m, 2H), 0.99 (t, J = 7.3 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ = 137.3 (d, J = 7 Hz, 2C), 132.5 (d, J = 21 Hz, 4C), 128.9 (2C), 128.6 (d, J = 8 Hz, 4C), 
110.6 (d, J = 4 Hz), 75.8 (d, J = 2 Hz), 30.8, 22.2, 20.3, 13.8; 31P NMR (162 MHz, CDCl3): δ = 31.3; IR 
(film): ṽ = 3054, 2957, 2929, 2870, 2178, 1585, 1478, 1434, 1323, 1209, 1095, 1025 cm-1; MS (EI) m/z 
(%): 266 (100) [M+], 237 (9), 224 (22), 209 (14), 178 (21), 145 (12), 115 (13), 91 (15); HRMS (ESI): m/z: 
calcd. for C18H19P: 226.1224; found: 226.1223.  
Hex-1-yn-1-yldiphenylphosphine oxide. Prepared analogously as a colorless solid (189 mg, 67%). Mp 
= 61-63 °C; 1H NMR (400 MHz, CDCl3): δ = 7.87-7.76 (m, 4H), 7.53-7.47 (m, 2H), 7.47-
7.40 (m, 4H), 2.44 (dt, J = 7.1, 3.5 Hz, 2H), 1.65-1.55 (m, 2H), 1.49-1.38 (m, 2H), 0.91 
(t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 133.6 (d, J = 121 Hz, 2C), 132.0 (d, J 
= 3 Hz, 2C), 130.9 (d, J = 11 Hz, 4C), 128.6 (d, J = 13 Hz, 4C), 109.8 (d, J = 30 Hz), 75.0 (d, J = 175 Hz), 
29.6 (d, J = 1 Hz), 22.0, 19.5 (d, J = 3 Hz), 13.5; 31P NMR (162 MHz, CDCl3): δ = 8.4; IR (film): ṽ = 3056, 
2958, 2931, 2871, 2190, 1590, 1437, 1202, 1119, 1105, 1069, 1027 957, 861 cm-1; MS (EI) m/z (%): 
282 (21) [M+], 254 (32), 240 (33), 201 (100), 115 (12), 77 (21), 51 (8); HRMS (ESI): m/z: calcd. for 
C18H19OP: 282.1174; found: 282.1172.  
(Hex-1-yn-1-yldiphenylphosphine)gold chloride. Prepared analogously as a colorless solid (46 mg, 
92%). Mp = 116-118 °C; 1H NMR (400 MHz, CDCl3): δ = 7.80-7.70 (m, 4H), 7.54-7.43 
(m, 6H), 2.51 (dt, J = 7.1, 3.4 Hz, 2H), 1.69-1.58 (m, 2H), 1.51-1.38 (m, 2H), 0.94 (t, J = 
7.3 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ = 133.0 (d, J = 16 Hz, 4C), 132.2 (d, J = 3 Hz, 
2C), 129.7 (d, J = 71 Hz, 2C), 129.4 (d, J = 13 Hz, 4C), 114.8 (d, J = 21 Hz), 69.2 (d, J = 123 Hz), 29.9, 
22.1, 20.1 (d, J = 3 Hz), 13.6; 31P NMR (162 MHz, CDCl3) ): δ = 3.8; IR (film): ṽ = 2953, 2935, 2869, 
2196, 1478, 1435, 1309, 1102, 983, 846 cm-1; Elemental analysis (%) calcd for C18H20AuClP: C 43.26, H 




Representative Procedure for Ring Opening Alkyne Metathesis. Preparation of Bis(4-
(dimethyl(phenyl)silyl)but-3-yn-1-yl) adipate: A suspension containing 
dimethyl(phenyl)(prop-1-yn-1-yl)silane (105 mg, 0.6 mmol), 1,8-
dioxacyclotetradec-11-yne-2,7-dione (45 mg, 0.2 mmol), complex 1 (17 mg, 
0.01 mmol, 5 mol%) and powdered MS 5Å (400 mg) in toluene (5 mL) was 
stirred for 24 h at 60°C. The mixture was then filtered through a pad of silica, the filtrate was 
evaporated, and the residue purified by flash chromatography (pentane/EtOAc, 95:5) to give the title 
compound as a colorless oil (80 mg, 77%). 1H NMR (400 MHz, CDCl3): δ = 7.65-7.58 (m, 4H), 7.41-7.35 
(m, 6H), 4.21 (t, J = 6.9 Hz, 4H), 2.62 (t, J = 6.9 Hz, 4H), 2.35-2.30 (m, 4H), 1.69-1.63 (m, 4H), 0.40 (s, 
12 H); 13C NMR (100 MHz, CDCl3): δ = 173.1 (2C), 137.2 (2C), 133.7 (4C), 129.5 (2C), 128.0 (4C), 104.3 
(2C), 84.6 (2C), 62.2 (2C), 33.8 (2C), 24.4 (2C), 20.6 (2C), 0.7 (4C); IR (film): ṽ = 3069, 2959, 2179, 
1735, 1428, 1248, 1165, 1115, 902, 836, 820, 779 cm-1; MS (EI) m/z (%): 518 (3) [M+], 441 (17), 315 
(5), 239 (6), 171 (12), 159 (100), 135 (42); HRMS (ESI): m/z: calcd. for C30H38O4Si2 + Na: 541.2201; 
found: 541.2199. 
Bis(4-(diphenylphosphino)but-3-yn-1-yl) adipate. Prepared analogously as a pale yellow oil (44 mg, 
36%); 1H NMR (400 MHz, CDCl3): δ = 7.64-7.54 (m, 8H), 7.37-7.29 (m, 12H), 4.26 
(t, J = 6.8 Hz, 4H), 2.78 (dt, J = 6.8, 1.5 Hz, 4H), 2.33-2.27 (m, 4H), 1.66-1.59 (m, 
4H); 13C NMR (100 MHz, CDCl3): δ = 173.1 (2C), 136.6 (d, J = 6 Hz, 4C), 132,6 (d, J 
= 21 Hz, 8C), 129.1 (4C), 128.7 (d, J = 7 Hz, 8C), 105.3 (d, J = 3 Hz, 2C), 78.4 (d, J = 
6 Hz, 2C), 62.1, (2C), 33.8 (2C), 24.4 (2C), 21.0 (2C); 31P NMR (162 MHz, CDCl3) ): δ = 33.3; IR (film): ṽ 
= 3053, 2956, 2185, 1732, 1478, 1434, 1163, 1136, 1067, 1024, 910 cm-1; MS (EI) m/z (%): 618 (3) 
[M+], 443 (20), 382 (44), 236 (100), 221 (35), 133 (22); HRMS (ESI): m/z: calcd. for C36H36O4P2 + Na: 
641.1981; found: 641.1987.  
Representative Procedure for the Metathesis of Terminal Alkynes. Preparation of Hex-3-yne-1,6-
diyl bis(4-methoxybenzoate): A suspension containing but-3-
yn-1-yl 4-methoxybenzoate (102 mg, 0.5 mmol), powdered MS 
5Å (2 g) and MS 4Å (1 g) in toluene (22 mL) was stirred for 5 
min at ambient temperature before a solution of complex 1 (5 
mg, 5 μmmol, 1 mol%) in toluene (2 mL) was added. The 
mixture was stirred for 1 h before it was filtered through a pad of Celite. The filtrate was evaporated 
and the residue purified by flash chromatography on alumina (toluene/EtOAc, 100:0  8:2) to give  
the title compound as a colorless solid (77 mg, 81%). Mp = 125-126 °C; 1H NMR (400 MHz, CDCl3): δ = 
7.99 (d, J = 8.8 Hz, 4H), 6.89 (d, J = 8.8 Hz, 4H), 4.35 (t, J = 6.7 Hz, 4H), 3.85 (s, 6H), 2.62 (t, J = 6.7 Hz, 
4H); 13C NMR (100 MHz, CDCl3): δ = 166.2 (2C), 163.5 (2C), 131.8 (4C), 122.6 (2C), 113.7 (4C), 77.7 
(2C), 62.9 (2C), 55.5 (2C), 19.5 (2C); IR (film): ṽ = 3006, 2958, 2897, 2839, 1706, 1604, 1509, 1459, 
1315, 1254, 1116, 1103, 1024, 984, 840 cm-1; MS (EI) m/z (%): 382 (8) [M+], 230 (5), 152 (100), 135 
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(80), 92 (6), 77 (10); HRMS (ESI): m/z: calcd. for C22H22O6 + Na: 405.1309; found: 405.1308. The 
analytical and spectroscopic data are in agreement with those reported in the literature. 5 
Hex-3-yne-1,6-diyl dibenzoate. Prepared analogously as a colorless solid (64 mg, 79%). Mp = 73-
74 °C; 1H NMR (400 MHz, CDCl3): δ = 8.04 (d, J = 7.3 Hz, 4H), 7.55 (dd, J = 
7.3, 7.3 Hz, 2H), 7.42 (dd, J = 7.3, 7.3 Hz, 4H), 4.39 (t, J = 6.5 Hz, 4H), 2.64 
(t, J = 6.5 Hz, 4H); 13C NMR (100 MHz, CDCl3): δ = 166.4 (2C), 133.1 (2C), 
130.2 (2C), 129.7 (4C), 128.5 (4C), 77.7 (2C), 63.2 (2C), 19.5 (2C); IR (film): 
ṽ = 2981, 2927, 1715, 1600, 1472, 1453, 1270, 1183, 1121, 1022, 978, 850 
cm-1; MS (EI) m/z (%): 322 (1) [M+], 200 (20), 105 (98), 78 (100), 51 (7);  HRMS (ESI): m/z: calcd. for 
C20H18O4 + Na: 345.1097; found: 345.1099. The analytical and spectroscopic data are in agreement 
with those reported in the literature.6  
Hex-3-yne-1,6-diyl bis(4-chlorobenzoate). Prepared analogously as a colorless solid (73 mg, 75%). 
Mp = 122-123 °C; 1H NMR (400 MHz, CDCl3): δ = 7.95 (d, J = 8.5 Hz, 
4H), 7.38 (d, J = 8.5 Hz, 4H), 4.37 (t, J = 6.7 Hz, 4H), 2.63 (t, J = 6.7 
Hz, 4H); 13C NMR (100 MHz, CDCl3): δ = 165.6 (2C), 139.7 (2C), 
131.1 (4C), 128.9 (4C), 128.6 (2C), 77.6 (2C), 67.4 (2C), 19.5 (2C); IR 
(film): ṽ = 2962, 2920, 2850, 1703, 1591, 1489, 1402, 1296, 1264, 
1120, 1106, 1016, 976, 855, 753cm-1; MS (EI) m/z (%): 413.3 [M + Na]+, 331.1 (1); HRMS (ESI): m/z: 
calcd. for C20H16Cl2O4 + Na: 413.0318; found: 413.0316. The analytical and spectroscopic data are in 
agreement with those reported in the literature. 5 
1,6-Bis(benzyloxy)hex-3-yne. Prepared analogously as a colorless oil (58 mg, 74%); 1H NMR (400 
MHz, CDCl3): δ = 7.36-7.27 (m, 10H), 4.55 (s, 4H), 3.57 (t, J = 7.0 Hz, 4H), 2.49 
(t, J = 7.0 Hz, 4H); 13C NMR (100 MHz, CDCl3): δ = 138.3 (2C), 128.5 (4C) 127.8 
(4C), 127.8(2C), 78.1(2C), 73.0 (2C), 68.8 (2C), 20.3 (2C); IR (film): ṽ = 3029, 
2911, 2859, 1495, 1453, 1362, 1204, 1095, 1028, 820 cm-1; MS (EI) m/z (%): 203 (2), 173 (5), 159 (4), 
129 (3), 105 (8), 91 (100), 77 (15), 65 (14); HRMS (ESI): m/z: calcd. for C20H22O2 + Na: 317.1512; found: 
317.1509. The analytical and spectroscopic data are in agreement with those reported in the 
literature.5 
1,6-Bis((tetrahydro-2H-pyran-2-yl)oxy)hex-3-yne. Prepared analogously as a pale yellow oil (58 mg, 
82%); 1H NMR (400 MHz, CDCl3): δ = 4.63 (t, J = 3.3 Hz, 2H), 3.92-3.83 (m, 
2H), 3.82-3.74 (m, 2H), 3.56-3.46 (m, 4H), 2.45 (t, J = 7.1 Hz, 4H), 1.90-1.77 
(m, 2H), 1.76-1.66 (m, 2H), 1.63-1.46 (m, 8H); 13C NMR (100 MHz, CDCl3): δ = 98.9 (2C), 78.0 (2C), 66.2 
(2C), 62.3 (2C), 30.7 (2C), 25.6 (2C), 20.4 (2C), 19.6 (2C); IR (film): ṽ = 2939, 2870, 1440, 1352, 1200, 
1134, 1120, 1068, 1032, 970, 906, 869, 814 cm-1; MS (EI) m/z (%): 197 (2), 153 (3), 125 (5), 101 (6), 85 
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(100), 79 (5), 67 (12), 55 (13), 41 (14); HRMS (ESI): m/z: calcd. for C16H26O4 + Na: 305.1723; found: 
305.1725.  
2,2,3,3,12,12,13,13-Octamethyl-4,11-dioxa-3,12-disilatetradec-7-yne. Prepared analogously as a 
yellow oil, (57 mg, 67%); 1H NMR (400 MHz, CDCl3): δ = 3.69 (t, J = 7.2 
Hz, 4H), 2.36 (t, J = 7.2 Hz, 4H), 0.90 (s, 18H), 0.07 (s, 12H); 13C NMR 
(100 MHz, CDCl3): δ = 78.3 (2C), 62.5 (2C), 26.1 (6C), 23.3 (2C), 18.5 
(2C), -5.12 (4C); IR (film): ṽ = 2954, 2929, 2857, 1472, 1361, 1253, 1097, 1058, 1006, 915, 334, 774 
cm-1; MS (EI) m/z (%): 327 (5), 285 (100), 255 (5), 189 (11), 155 (45), 147 (35), 115 (12), 89 (23), 73 
(80); HRMS (ESI): m/z: calcd. for C18H38O2Si2 + Na: 365.2303; found: 365.2303.  
N,N'-(Dec-5-yne-1,10-diyl)bis(N-benzyl-4-methylbenzenesulfonamide). Prepared analogously as a 
white solid; (69 mg, 42%); M. p. = 91-93°C; 1H NMR (400 MHz, CDCl3): δ 
= 7.73 (d, J = 8.0 Hz, 4H), 7.34-7.24 (m, 14H), 4.30 (s, 4H), 3.09 (t, J = 7.3 
Hz, 4H), 2.44 (s, 6H), 1.94 (t, J = 6.6 Hz, 4H), 1.46-1.36 (m, 4H), 1.31-1.22 
(m, 4H); 13C NMR (100 MHz, CDCl3): δ = 143.3 (2C), 137.2 (2C), 136.6 
(2C), 129.8 (4C), 128.7 (4C), 128.4 (4C), 127.9 (2C), 127.3 (4C), 79.9 (2C), 52.1 (2C), 47.8 (2C), 27.3 
(2C), 26.1 (2C), 21.6 (2C), 18.3 (2C); IR (film): ṽ = 3034, 2942, 2865, 1599, 1494, 1455, 1323, 1309, 
1149, 1087, 1025, 934, 813 cm-1; MS (EI) m/z (%): 656 (1) [M+], 501 (50), 345 (2), 300 (22), 274 (14), 
155 (4), 91 (100); HRMS (ESI): m/z: calcd. for C38H44N2O4S2 + Na: 679.2635; found: 679.2643. 
Di-tert-butyl dec-5-yne-1,10-diylbis(benzylcarbamate). Prepared analogously as a colorless oil, 
(116 mg, 85%); 1H NMR (400 MHz, CDCl3): δ = 7.32-7.26 (m, 4H), 
7.25-7.18 (m, 6H), 4.41 (bs, 4H), 3.20 and 3.12 (bs, rotamers, 
4H), 2.11 (t, J = 6.0 Hz, 4H), 1.66-1.36 (m, 26H); 13C NMR (100 
MHz, CDCl3): δ = 156.1 and 155.7 (2C, rotamers), 138.6 (2C), 128.5 (4C), 127.7 (2C), 127.1 
(4C), 80.1 (2C), 79.6 (2C), 50.4 and 49.8 (2C, rotamers), 46.0 (2C), 28.5 (6C), 27.3 (2C), 26.4 
(2C), 18.5 (2C); MS (EI) m/z (%): 548 (1) [M+], 448 (27), 392 (51), 375 (16), 347 (12), 257 (40), 
200 (18), 146 (39), 120 (34), 106 (30), 91 (100), 57 (87); HRMS (ESI): m/z: calcd. for C34H48N2O4 
+ H: 549.3687; found: 549.3690. 
Representative Procedure for the Cross Metathesis of Terminal Alkynes. Preparation of 4-
(Trimethylsilyl)but-3-yn-1-yl 4-methoxybenzoate: A suspension containing 
but-3-yn-1-yl 4-methoxybenzoate (102 mg, 0.5 mmol), trimethyl(prop-1-yn-
1-yl)silane (148 μL, 2 mmol), powdered MS 5Å (2 g) and MS 4Å (1 g) in 
toluene (22 mL) was stirred for 5 min before a solution of complex 1 (5 mg, 5 
μmmol, 1 mol%) in toluene (2 mL) was added. After stirring for 1 h, the mixture was filtered through 
a pad of Celite and the filtrate was evaporated. Purification of the residue by flash chromatography 
over alumina (toluene/EtOAc, 100:0  95:5) afforded the cross metathesis product as a colorless oil 
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(133 mg, 96%). 1H NMR (400 MHz, CDCl3): δ = 8.01 (d, J = 9.0 Hz, 2H), 6.91 (d, J = 9.0 Hz, 2H), 4.38 (t, J 
= 7.0 Hz, 2H), 3.86 (s, 3H), 2.68 (t, J = 7.0 Hz, 2H), 0.15 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 166.1, 
163.6, 131.8 (2C), 122.7, 113.7 (2C), 102.5, 86.7, 62.5, 55.6, 20.7, 0.1 (3C); IR (film): ṽ = 2960, 2901, 
2840, 2179, 1713, 1606, 1511, 1248, 1166, 1100, 1029, 842 cm-1; MS (EI) m/z (%): 276 (8) [M+], 261 
(8), 231 (6), 209 (6), 189 (8), 165 (7), 152 (100), 135 (85), 107 (6), 92 (8), 77 (10); HRMS (ESI): m/z: 
calcd. for C15H20O3Si + Na: 299.1074; found: 299.1076. 
4-(Trimethylsilyl)but-3-yn-1-yl 4-chlorobenzoate. Prepared analogously as a yellow syrup, (132 mg, 
94%); 1H NMR (400 MHz, CDCl3): δ = 7.99 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 8.5 Hz, 
2H), 4.41 (t, J = 6.9 Hz, 2H), 2.69 (t, J = 6.9 Hz, 2H), 0.14 (s, 9H); 13C NMR (100 
MHz, CDCl3): δ = 165.6, 139.7, 131.2 (2C), 128.9 (2C), 128.7, 102.2, 87.0, 63.0, 
20.6, 0.11 (3C); IR (film): ṽ = 2961, 2852, 2179, 1722, 1595, 1488, 1402, 1266, 
1249, 1103, 1091, 1015, 838 cm-1; MS (EI) m/z (%): 265 (18), 235 (15), 213 (18), 193 (12), 169 (12), 
141 (31), 139 (100), 124 (82), 111 (49), 109 (79), 75 (20); HRMS (ESI): m/z: calcd. for C14H17ClO2Si + 
Na: 303.0579; found: 303.0576. 
Trimethyl(4-((tetrahydro-2H-pyran-2-yl)oxy)but-1-yn-1-yl)silane. Prepared analogously as a 
colorless oil, (99 mg, 88%); 1H NMR (400 MHz, CDCl3): δ = 4.66 (t, J = 3.2 Hz, 1H), 
3.92-3.86 (m, 1H), 3.85-3.77 (m, 1H), 3.58-3.47 (m, 2H), 2.54 (t, J = 7.2 Hz, 2H), 
1.89-1.77 (m, 1H), 1.75-1.66 (m, 1H), 1.64-1.46 (m, 4H); 0.14 (s, 9H); 13C NMR 
(100 MHz, CDCl3): δ = 104.1, 98.7, 85.7, 65.7, 62.2, 30.7, 25.6, 21.5, 19.4, 0.2 (3C); IR (film): ṽ = 2942, 
2873, 2178, 1441, 1352, 1258, 1200, 1122, 1032, 907, 836, 815, 759 cm-1; MS (EI) m/z (%): 173 (5), 
127 (28), 109 (10), 99 (15), 85 (10), 75 (50), 55 (19); HRMS (ESI): m/z: calcd. for C12H22O2Si + Na: 
249.1281; found: 249.1280. The analytical and spectroscopic data are in agreement with those 
reported in the literature.7 
N-Benzyl-4-methyl-N-(6-(trimethylsilyl)hex-5-yn-1-yl)benzenesulfonamide. Prepared analogously as 
a colorless oil, (188 mg, 91%); 1H NMR (400 MHz, CDCl3): δ = 7.71 (d, J = 8.1 Hz, 
2H), 7.33-7.23 (m, 7H), 4.30 (s, 2H), 3.08 (t, J = 7.2 Hz, 2H), 2.42 (s, 3H), 2.04 (t, J = 
6.9 Hz, 2H), 1.48-1.37 (m, 2H), 1.36-1.26 (m, 2H), 0.11 (s, 9H); 13C NMR (100 MHz, 
CDCl3): δ = 143.3, 137.2, 136.6, 129.8 (2C), 128.7 (2C), 128.4 (2C), 127.9, 127.3 
(2C), 106.9, 84.9, 52.0, 47.6, 27.2, 25.7, 21.6, 19.4, 0.3 (3C); IR (film): ṽ = 3031, 2956, 2866, 2172, 
1599, 1495, 1455, 1338, 1248, 1156, 1089, 1023, 840, 758 cm-1; MS (EI) m/z (%): 398 (11), 322 (2), 
300 (35), 274 (14), 258 (27), 184 (5), 149 (3), 91 (100), 73 (9); HRMS (ESI): m/z: calcd. for C23H31NO2SSi 
+ Na: 436.1737; found: 436.1741. 
tert-Butyl benzyl(6-(trimethylsilyl)hex-5-yn-1-yl)carbamate. Prepared 
analogously as a colorless oil, (167 mg, 93%); 1H NMR (400 MHz, CDCl3): δ = 7.34-
7.27 (m, 2H), 7.26-7.18 (m, 3H), 4.43 (bs, 2H), 3.21 and 3.13 (bs, rotamers, 2H), 
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2.20 (t, J = 6.9 Hz, 2H), 1.66-1.37 (m, 13H), 0.13 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 156.1 and 
155.7 (1C, rotamers), 138.5, 128.5 (2C), 127.8, 127.2 (2C), 107.1, 84.8, 79.7, 50.4 and 49.8 (1C, 
rotamers), 45.9, 28.5 (3C), 27.2, 25.9, 19.7, 0.3 (3C); IR (film): ṽ = 2960, 2932, 2861, 2174, 1691, 1454, 
1414, 1365, 1248, 1156, 1117, 1028, 834 cm-1; MS (EI) m/z (%): 359 (2) [M+], 303 (11), 288 (29), 258 
(16), 212 (13), 190 (32), 186 (22), 168 (17), 146 (24), 120 (30), 91 (100), 73 (28), 57 (70); HRMS (ESI): 
m/z: calcd. for C21H33NO2Si + Na: 382.2173; found: 382.2170. 
 
Total Synthesis of Dehydrocurvularin 
 
Compound S5: CBr4 (27.0 g, 81.5 mmol) and PPh3 (21.4 g, 81.5 mmol) were added in several portions 
to a stirred solution of pent-3-yn-1-ol (4.57 g, 54.3 mmol) in CH2Cl2 (160 mL) at 0 °C. 
The mixture was stirred at ambient temperature for 1 h and at reflux temperature for 
2 h. The solvent was evaporated and the residue suspended in pentane, which was also evaporated. 
The remaining white solid was suspended in pentane/Et2O (90:10), the suspension was filtered and 
the solid carefully rinsed with the same solvent. The combined filtrates were evaporated and the 
residue was purified by flash chromatography (pentane/Et2O, 100/0  95/5) to give product S5 as a 
colorless oil (7.10 g, 89%). 1H NMR (400 MHz, CDCl3): δ = 3.41 (t, J = 7.4 Hz, 2H), 2.69 (tq, J = 7.4, 2.5 
Hz, 2H), 1.79 (t, J = 2.5, 3H); 13C NMR (100 MHz, CDCl3): δ = 78.0 (C), 76.2 (C), 30.4 (CH2), 23.4 (CH2), 
3.6 (CH3); IR (film): ṽ = 2968, 2920, 2854, 1436, 1334, 1271, 1212 cm
-1; MS (EI): m/z (%):  148 (26), 
146 (26), 68 (5), 67 (100), 66 (17), 65 (20), 63 (7), 53 (19), 51 (10), 50 (6), 41 (61), 39 (41), 38 (6), 27 
(15); HRMS (EI): m/z: calcd for C5H7Br [M]
+: 145.9731; found 145.9730. 
Compound S6: A solution of bromide S5 (1.00 g, 6.8 mmol) in THF (4 mL) was added dropwise to a 
suspension of activated magnesium8 (230 mg, 9.5 mmol) in THF (6 mL) at 0 °C. The 
mixture was stirred for 20 min at ambient temperature before it was cooled to 
78 °C. CuCN (61 mg, 0.68 mmol) and (S)-propylene oxide (0.24 mL, 3.4 mmol) were added and the 
resulting mixture was allowed to reach ambient temperature overnight. The reaction was quenched 
with sat. aq. NH4Cl and diluted with tert-butyl methyl ether and water. The aqueous layer was 
extracted with tert-butyl methyl ether, the combined organic phases were dried over Na2SO4 and 
evaporated, and the residue was purified by flash chromatography (hexanes/EtOAc, 94/6  90/10) 
to afford product S6 as a colorless oil (450 mg, 97%).  20D = +10.4° (c = 1.2, CHCl3); 
1H NMR (400 
MHz, CDCl3): δ = 3.86-3.78 (m, 1H), 2.19-2.12 (m, 2H) 1.77 (t, J = 2.7, 3H), 1.64-1.46 (m, 5H), 1.35 (br 
s, 1H), 1.20 (d, J = 6.1, 3H); 13C NMR (100 MHz, CDCl3): δ = 79.1 (C), 75.9 (C), 67.9 (CH), 38.6 (CH2), 
25.4 (CH2), 23.7 (CH3), 18.8 (CH2), 3.6 (CH3); IR (film): ṽ = 3357, 2964, 2920, 2862, 1455, 1435, 1373, 
1332, 1127, 1084, 1044, 990, 944, 862 cm-1; MS (EI): m/z (%):  111 (30), 109 (5), 108 (5), 107 (5), 97 
(5), 94 (9), 93 (99), 91 (17), 84 (91), 83 (10), 81 (14), 79 (24), 77 (22), 71 (45), 69 (5), 68 (21), 67 (66), 
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66 (100), 65 (17), 58 (6), 57 (11), 55 (33), 54 (44), 53 (29), 52 (8), 51 (11), 50 (5), 45 (83), 43 (50), 42 
(5), 41 (35), 40 (8), 39 (33), 29 (14), 27 (30); HRMS (CI): m/z calcd for C8H15O+H [M+H]
+: 127.1123; 
found 127.1122. 
Compound 31: Ac2O (0.78 mL, 8.24 mmol), DMAP (101 mg, 0.82 mmol) and NEt3 (1.71 mL, 12.4 
mmol) were added to a stirred solution of alcohol S6 (520 mg, 4.12 mmol) in 
CH2Cl2 (15 mL). After stirring for 1.5 h, the reaction was quenched with water 
and the mixture diluted with tert-butyl methyl ether. The aqueous layer was extracted with tert-butyl 
methyl ether and the combined organic phases were dried over Na2SO4 and evaporated. The residue 
was purified by flash chromatography (hexanes/EtOAc, 100/0  98/2) to furnish product 31 as a 
colorless oil (679 mg, 98%).  20D = +1.2° (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 4.90 (tq, J = 
6.3, 6.3 Hz, 1H), 2.17-2.10 (m, 2H), 2.02 (s, 3H), 1.77 (t, J = 2.5, 3H), 1.69-1.57 (m, 2H), 1.54-1.41 (m, 
2H), 1.21 (d, J = 6.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 170.9 (C), 78.8 (C), 76.0 (C), 70.7 (CH), 
35.2 (CH2), 25.1 (CH2), 21.5 (CH3), 20.1 (CH3), 18.7 (CH2), 3.6 (CH3); IR (film): ṽ = 2978, 2940, 2921, 
2866, 1733, 1436, 1371, 1238, 1132, 1083, 1043, 1017, 953 cm-1; MS (EI): m/z (%): 126 (22), 111 (15), 
108 (14), 94 (5), 93 (77), 91 (11), 87 (5), 84 (7), 79 (15), 77 (9), 71 (8), 67 (9), 66 (67), 55 (19), 53 (9), 
43 (100), 41 (9), 39 (6), 27 (7); HRMS (CI): m/z calcd for C10H17O2+H [M+H]
+: 169.1229; found 
169.1227. 
Compound S7: A solution of 1-propynylmagnesium bromide (0.5 M in THF, 6.2 mL, 3.10 mmol) was 
added dropwise to a stirred solution of aldehyde 29 (600 mg, 2.45 mmol)9 in 
THF (4.5 mL) at 0 °C. After stirring at ambient temperature overnight, the 
reaction was quenched with sat. aq. NH4Cl and tert-butyl methyl ether. The 
aqueous layer was extracted with tert-butyl methyl ether and the combined extracts were dried over 
Na2SO4 and evaporated. The residue was purified by flash chromatography (hexanes/EtOAc, 90/10  
85/15) to give product S7 as a colorless solid (649 mg, 93%). Mp = 90-91 °C; 1H NMR (400 MHz, 
CDCl3): δ =  6.68 (d, J = 2.4 Hz, 1H), 6.45 (d, J = 2.4 Hz, 1H), 5.81 (dq, J = 11.1, 2.3 Hz, 1H), 3.89 (s, 3H), 
3.80 (d, J = 11.1 Hz, 1H), 3.77 (s, 3H), 1.82 (d, J = 2.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 160.3 (C), 
159.1 (C), 123.1 (C), 122.3 (C), 109.7 (CH), 99.7 (CH), 80.7 (C), 79.1 (C), 62.9 (CH), 56.3 (CH3), 55.8 
(CH3), 4.0 (CH3); IR (film): ṽ = 3529, 3090, 2972, 2943, 2839, 1595, 1566, 1482, 1465, 1451, 1433, 
1409, 1302, 1209, 1177, 1143, 1125, 1029, 1005, 947, 832, 811, 795, 721 cm-1; MS (EI): m/z (%):  286 
(8), 284 (8), 271 (13), 169 (17), 255 (6), 253 (7), 218 (7), 206 (13), 205 (100), 190 (14), 162 (11), 161 
(7), 147 (7), 67 (7), 63 (5), 39 (7); HRMS (ESI): m/z calcd for C12H13O3BrNa [M+Na]
+: 306.9940; found 
306.9938. 
Compound 30: Imidazole (402 mg, 5.9 mmol) and TBSCl (1.07 g, 7.1 mmol) were added to a stirred 
solution of alcohol S7 (1.35 g, 4.9 mmol) in DMF (4 mL) at 0 °C. After stirring at 
ambient temperature for 4 h, the reaction was quenched with water and the 
mixture diluted with tert-butyl methyl ether. The aqueous layer was extracted 
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with tert-butyl methyl ether and the combined organic phases were dried over Na2SO4 and 
evaporated. The residue was purified by flash chromatography (hexanes/EtOAc, 98/2  96/4) to give 
product 30 as a colorless oil (1.92 g, 98%). 1H NMR (400 MHz, CDCl3): δ =  6.71 (d, J = 2.5 Hz, 1H), 6.39 
(d, J = 2.5 Hz, 1H), 6.08 (q, J = 2.3 Hz, 1H), 3.81 (s, 3H), 3.77 (s, 3H), 1.81 (d, J = 2.3 Hz, 3H), 0.86 (s, 
9H), 0.09 (s, 3H), 0.02 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 160.1 (2 C), 124.2 (C), 122.8 (C), 110.4 
(CH), 98.9 (CH), 79.8 (C), 79.5 (C), 56.2 (CH), 56.2 (CH3), 55.7 (CH3), 26.0 (CH3), 18.4 (C), 4.1 (CH3), 4.5 
(CH3), 4.7 (CH3); IR (film): ṽ = 2955, 2929, 2855, 1598, 1567, 1460, 1434, 1410, 1300, 1286, 1249, 
1214, 1199, 1155, 1126, 1060, 1035, 1004, 938, 831, 812, 773 cm-1; MS (EI): m/z (%): 344 (16), 343 
(80), 342 (16), 341 (77), 270 (13), 269 (98), 268 (13), 267 (100), 217 (4), 215 (5), 188 (7), 173 (8), 145 
(5), 115 (7), 102 (5), 97 (9), 75 (11), 73 (15), 53 (7), 41 (5); HRMS (ESI): m/z calcd for C18H27O3BrSiNa 
[M+Na]+: 421.0805; found 421.0805. 
Compound 32: A solution of TMPZnCl∙LiCl (1.0 M in THF, 2.8 mL, 2.8 mmol)10 was added dropwise to 
a stirred solution of acetate 31 (316 mg, 1.9 mmol) in THF (6 mL). The 
mixture was stirred for 20 min at ambient temperature before Pd(OAc)2 
(22 mg, 0.095 mmol), SPhos (78 mg, 0.19 mmol) and a solution of 
bromide 30 (760 mg, 1.9 mmol) in THF (5 mL) were successively added. 
The resulting mixture was heated to 50 °C for 3 h, before the reaction was quenched with sat. aq. 
NH4Cl. The aqueous layer was extracted with CH2Cl2 and the combined extracts were dried over 
Na2SO4 and evaporated. The residue was purified by flash chromatography (hexanes/EtOAc, 98/2  
95/5) to afford product 32 as a pale orange oil (566 mg, 62%, mixture of diastereomers).  20D = +3.3° 
(c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3): δ =  6.42 (d, J = 2.5 Hz, 1H, 1 dia.), 6.41 (d, J = 2.5 Hz, 1H, 1 
dia.), 6.31 (d, J = 2.3 Hz, 2H, 2 dia.), 6.09 (q, J = 2.2 Hz, 2H, 2 dia.), 4.99-4.89 (m, 2H, 2 dia.), 4.18 (d, J 
= 16.7 Hz, 1H, 1 dia.), 4.17 (d, J = 16.8 Hz, 1H, 1 dia.), 4.07 (d, J = 16.7 Hz, 1H, 1 dia.), 4.06 (d, J = 16.8 
Hz, 1H, 1 dia.), 3.77 (s, 6H, 2 dia.), 3.76 (s, 6H, 2 dia.), 2.15-2.07 (m, 4H, 2 dia.), 1.77 (d, J = 2.3 Hz, 3H, 
1 dia., overlap), 1.77 (d, J = 2.3 Hz, 3H, 1 dia., overlap), 1.75 (t, J = 2.5 Hz, 6H, 2 dia.), 1.72-1.58 (m, 
4H, 2 dia.), 1.58-1.41 (m, 4H, 2 dia.), 1.22 (d, J = 6.0 Hz, 6H, 2 dia.), 0.85 (s, 18H, 2 dia.), 0.07 (s, 6H, 2 
dia.), -0.06 (s, 6H, 2 dia.); 13C NMR (100 MHz, CDCl3): δ = 171.9 (C), 171.9 (C), 159.8 (C, 2 dia.), 156.5 
(C, 2 dia.), 136.8 (C), 136.8 (C), 122.4 (C, 2 dia.), 107.6 (CH), 107.6 (CH), 97.2 (CH, 2 dia.), 80.5 (C), 
80.4 (C), 78.9 (C, 2 dia.), 75.9 (C, 2 dia.), 70.8 (CH), 70.8 (CH), 56.6 (CH3), 55.9 (CH3, 2 dia.), 55.3 (CH3), 
38.4 (CH2), 38.3,(CH2), 35.4 (CH2), 35.3 (CH2), 26.0 (CH3, 2 dia.), 25.1 (CH2, 2 dia.), 20.1 (CH3, 2 dia.), 
18.8 (CH2, 2 dia.), 18.3 (C, 2 dia.), 4.0 (CH3, 2 dia.), 3.6 (CH3, 2 dia.), -4.9 (CH3, 2 dia.), -4.9 (CH3, 2 dia.); 
IR (film): ṽ = 2929, 2856, 1728, 1604, 1462, 1427, 1360, 1302, 1250, 1203, 1166, 1148, 1129, 1080, 
1030, 1003, 858, 834, 775 cm-1; MS (EI): m/z (%): 486 (1), 431 (5), 430 (16), 429 (51), 361 (12), 323 
(7), 322 (24), 321 (100), 307 (4), 305 (9), 304 (15), 303 (64), 281 (10), 277 (14), 262 (6), 261 (10), 253 
(6), 248 (7), 247 (40), 246 (6), 245 (7), 229 (19), 203 (6), 202 (7), 201 (14), 188 (7), 187 (10), 159 (11), 
144 (6), 128 (6), 116 (5), 115 (7), 109 (19), 81 (11), 75 (22), 73 (18), 67 (25), 66 (6), 57 (14), 55 (15), 53 
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(10), 43 (13), 41 (17), 29 (7); HRMS (ESI): m/z calcd for C28H42O5SiNa [M+Na]
+: 509.2694; found 
509.2699. 
Compound 33: A two-neck flask with a reflux condenser was charged with diyne 32 (155 mg, 0.32 
mmol) in degassed toluene (35 mL) under Ar. Complex 6 (100 mg, 0.16 
mmol)11 and degassed abs. CH2Cl2 (0.51 mL, 7.95 mmol) were added and the 
mixture was stirred at reflux temperature for 18 h. After cooling, the mixture 
was passed through a pad of silica, which was carefully rinsed with ethyl 
acetate. The combined filtrates were evaporated and the residue was purified by flash 
chromatography (hexanes/EtOAc, 98/2  93/7) to give product 33 as a colorless solid (109 mg, 79%). 
For analytical reasons an aliquot of the sample was re-subjected to flash chromatography to afford 
analytically pure samples of both diastereomers, which analyzed as follows: 
First diastereomer:  20D = 53.2° (c = 1.0, CHCl3);
 1H NMR (400 MHz, CDCl3): δ = 6.32 (d, J = 2.5 Hz, 
1H), 6.29 (d, J = 2.5 Hz, 1H), 6.11-6.09 (m, 1H), 5.03-4.93 (m, 1H), 4.86 (d, J = 17.1 Hz, 1H), 3.80 (s, 
3H), 3.77 (s, 3H), 3.46 (d, J = 17.1 Hz, 1H), 2.36-2.27 (m, 1H), 2.10-2.00 (m, 1H), 1.80-1.64 (m, 2H), 
1.56-1.39 (m, 2H), 1.04 (d, J = 6.3 Hz, 3H), 0.84 (s, 9H), 0.09 (s, 3H), -0.09 (s, 3H); 13C NMR (100 MHz, 
CDCl3): δ = 172.1 (C), 159.7 (C), 156.5 (C), 137.4 (C), 122.7 (C), 108.2 (CH),  96.9 (CH), 85.2 (C), 81.8 
(C), 71.5 (CH), 56.5 (CH), 55.8 (CH3), 55.4 (CH3), 39.6 (CH2), 34.9 (CH2), 25.9 (CH3), 23.9 (CH2), 20.4 
(CH2), 20.2 (CH3), 18.3 (C), 4.8 (CH3), 5.0 (CH3); IR (film): ṽ = 2932, 2856, 1717, 1604, 1462, 1426, 
1360, 1322, 1250, 1204, 1147, 1131, 1083, 1057, 1027, 1003, 856, 834, 775 cm-1; MS (EI): m/z (%):  
377 (7), 376 (27), 375 (100), 358 (7), 357 (26), 302 (9), 301 (41), 283 (15), 282 (5), 281 (27), 259 (8), 
257 (6), 255 (13), 253 (6), 243 (5), 242 (5), 231 (19), 205 (5), 204 (5), 201 (6), 191 (5), 179 (5), 175 (5), 
109 (5), 105 (9), 75 (17), 73 (16); HRMS (ESI): m/z calcd for C24H36O5SiNa [M+Na]
+: 455.2224; found 
455.2224. 
Second diastereomer: Mp = 147-148 °C;  20D = 46.5° (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 
6.45 (d, J = 2.5 Hz, 1H), 6.34 (d, J = 2.5 Hz, 1H), 6.10 (t, J = 1.5 Hz, 1H), 5.12-5.04 (m, 1H), 4.69 (d, J = 
16.7 Hz, 1H), 3.81 (s, 3H), 3.77 (s, 3H), 3.36 (d, J = 16.7 Hz, 1H), 2.39-2.29 (m, 1H), 2.14-2.04 (m, 1H), 
1.95-1.85 (m, 1H), 1.77-1.60 (m, 3H), 1.25 (d, J = 6.6 Hz, 3H), 0.87 (s, 9H), 0.13 (s, 3H), -0.05 (s, 3H); 
13C NMR (100 MHz, CDCl3): δ = 172.7 (C), 159.8 (C), 156.6 (C), 136.6 (C), 121.9 (C), 109.8 (CH), 97.5 
(CH), 86.2 (C), 81.6 (C), 70.9 (CH), 56.4 (CH), 55.8 (CH3), 55.4 (CH3), 38.5 (CH2), 34.0 (CH2), 26.0 (CH3), 
21.9 (CH2), 20.2 (CH2), 19.4 (CH3), 18.3 (C), 4.8 (CH3), 4.8 (CH3); IR (film): ṽ = 2950, 2932, 2856, 
1726, 1606, 1460, 1427, 1356, 1304, 1275, 1247, 1202, 1185, 1168, 1147, 1129, 1083, 1064, 1043, 
1020, 1002, 942, 857, 836, 773 cm-1; MS (EI): m/z (%): 377 (8), 376 (27), 375 (100), 357 (16), 302 (16), 
301 (73), 283 (14), 281 (18), 259 (15), 257 (6), 255 (11), 253 (5), 243 (6), 241 (5), 232 (5), 231 (32), 
217 (6), 207 (5), 205 (5), 204 (5), 201 (7), 179 (5), 175 (5), 115 (5), 109 (5), 105 (6), 75 (17), 73 (18), 69 
(6), 57 (5), 55 (6), 41 (7); HRMS (ESI): m/z calcd for C24H36O5SiNa [M+Na]
+: 455.2224; found 455.2220. 
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Compound S8: H2O (31 μL, 1.7 mmol) and TASF (235 mg, 0.85 mmol) were 
added to a stirred solution of compound 33 (74 mg, 0.17 mmol) in DMF (2.5 
mL). After stirring for 2.5 h, the reaction was quenched with aqueous pH 7 
buffer and the mixture diluted with ethyl acetate. The aqueous layer was 
extracted with ethyl acetate and the combined extracts were dried over Na2SO4 and evaporated. The 
residue was purified by flash chromatography (hexanes/EtOAc, 90/10  80/20) to give product S8 as 
a colorless foam (52 mg, 97%, 2 diastereomers).  20D = 9.1° (c = 0.8, CHCl3); 
1H NMR (400 MHz, 
CDCl3): δ = 6.43 (d, J = 2.4 Hz, 2H, 2 dia.), 6.38 (d, J = 2.4 Hz, 1H, 1 dia.), 6.27 (d, J = 2.4 Hz, 1H, 1 dia.), 
6.20-6.14 (m, 1H, 1 dia.), 5.94 (dt, J = 8.2, 2.0 Hz, 1H, 1 dia.), 5.14-5.04 (m, 2H, 2 dia.), 4.58 (d, J = 16.6 
Hz, 1H, 1 dia.), 4.12 (d, J = 17.9 Hz, 1H, 1 dia.), 3.85 (d, J = 17.9 Hz, 1H, 1 dia.), 3.84 (s, 3H, 1 dia.), 3.81 
(s, 3H, 1 dia.), 3.79 (s, 3H, 1 dia.), 3.79 (s, 3H, 1 dia.), 3.49 (d, J = 9.0 Hz, 1H, 1 dia.), 3.45 (d, J = 16.9 
Hz, 1H, 1 dia.), 2.46-2.36 (m, 1H, 1 dia.), 2.35-2.29 (m, 2H, 1 dia.), 2.11-2.07 (m, 1H, 1 dia.), 2.07-2.00 
(m, 1H, 1 dia.), 1.98-1.88 (m, 1H, 1 dia.), 1.88-1.77 (m, 1H, 1 dia.), 1.77-1.70 (m, 1H, 1 dia.), 1.70-1.56 
(m, 4H, 2 dia.), 1.24 (d, J = 6.4 Hz, 3H, 1 dia., overlap), 1.24 (d, J = 6.4 Hz, 3H, 1 dia., overlap); 13C NMR 
(100 MHz, CDCl3): δ = 173.7 (C), 172.3 (C), 160.3 (C), 160.1 (C), 158.8 (C), 157.6 (C), 136.3. (C), 134.8 
(C), 120.9 (C), 120.2 (C), 110.0 (CH), 109.1 (CH), 98.1 (CH), 97.9 (CH), 88.3 (C), 88.0 (C), 82.1 (C), 80.5 
(C), 72.6 (CH), 71.1 (CH), 57.1 (CH), 56.5 (CH), 56.2 (CH3), 55.9 (CH3), 55.5 (CH3), 55.4 (CH3), 42.0 (CH2), 
39.2 (CH2), 33.6 (CH2), 33.4 (CH2), 23.6 (CH2), 21.7 (CH2), 20.1 (CH3), 20.0 (CH3), 19.3 (CH2), 19.3 (CH3); 
IR (film): ṽ = 3479, 2935, 2839, 1714, 1603, 1454, 1426, 1306, 1202, 1144, 1082, 1052, 980, 949, 833, 
729 cm-1; MS (EI): m/z (%): 319 (10), 318 (49), 303 (21), 302 (20), 301 (100), 300 (24), 275 (51), 273 
(32), 272 (16), 271 (10), 259 (40), 257 (25), 247 (20), 243 (21), 241 (26), 233 (38), 231 (54), 229 (32), 
220 (21), 219 (21), 218 (37), 217 (97), 207 (38), 205 (63), 204 (33), 203 (30), 202 (30), 201 (51), 196 
(21), 191 (58), 189 (38), 187 (25), 179 (38), 178 (25), 175 (36), 165 (22), 161 (22), 152 (28), 151 (32), 
128 (30), 121 (20), 115 (49), 91 (26), 77 (34), 55 (35), 43 (38), 41 (32), 39 (20), 29 (22); HRMS (ESI): 
m/z calcd for C18H22O5Na [M+Na]
+: 341.1359; found 341.1359. 
Compound 34: MnO2 (316 mg, 3.6 mmol) was added in several portions over a period of 2 h to a 
stirred solution of alcohol S8 (58 mg, 0.18 mmol) in CH2Cl2 (1.5 mL). Stirring was 
continued for 30 min before the mixture was passed through a pad of silica, 
which was carefully rinsed with tert-butyl methyl ether. The combined filtrates 
were evaporated and the residue purified by flash chromatography 
(hexanes/EtOAc, 85/15  50/50) to give product 34 as a yellowish solid (44 mg, 
77%). Mp = 117-119 °C;  20D = 116° (c = 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 6.42 (d, J = 2.3 
Hz, 1H), 6.40 (d, J = 2.3 Hz, 1H), 5.16-5.07 (m, 1H), 3.91 (d, J = 16.4 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 
3.53 (d, J = 16.4 Hz, 1H), 2.55 (ddd, J = 17.5, 8.5, 2.9 Hz, 1H), 2.41 (ddd, J = 17.5, 8.8, 2,8 Hz, 1H), 1.99-
1.89 (m, 1H), 1.88-1.77 (m, 1H), 1.76-1.62 (m, 2H), 1.25 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3): 
δ = 178.9 (C), 171.2 (C), 162.2 (2), 159.1 (C), 135.0 (C), 122.7 (C), 108.6 (CH), 98.4 (CH), 98.0 (C), 83.5 
(C), 71.7 (CH), 56.2 (CH3), 55.6 (CH3), 40.0 (CH2), 33.9 (CH2), 21.6 (CH2), 20.5 (CH2), 19.5 (CH3); IR 
(film): ṽ = 2978, 2923, 2847, 2219, 2185, 1723, 1636, 1600, 1455, 1442, 1422, 1365, 1319, 1250, 
1213, 1199, 1159, 1142, 1086, 1066, 1044, 981, 961, 902, 883, 858, 847, 816, 785, 743, 716 cm -1; MS 
S-26 
 
(EI): m/z (%): 317 (20), 316 (100), 300 (12), 299 (63), 245 (11), 244 (10), 230 (10), 229 (12), 215 (14), 
189 (10), 178 (16), 128 (13), 115 (26), 91 (10), 77 (14); HRMS (ESI): m/z calcd for C18H20O5Na [M+Na]
+: 
339.1203; found 339.1202. 
Compound 35: CrCl2 (57 mg, 0.46 mmol) was added to a stirred solution of compound 34 (21.0 mg, 
0.066 mmol) in degassed THF/H2O (1:1, 1.5 mL). After 3.5 h, a second portion of 
CrCl2 (25 mg, 0.20 mmol) was introduced and stirring continued for 1 h. The 
reaction was quenched with H2O and tert-butyl methyl ether, the organic layer 
was washed with H2O, dried over Na2SO4 and evaporated. The residue was 
purified by flash chromatography (hexanes/EtOAc, 90/10  85/15) to give product E-35 as a 
colorless foam (14.9 mg, 71%) together with (Z)-isomer Z-35 (1.4 mg, 7%).  20D = 58.0° (c = 1.0, 
CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 6.50-6.39 (m, 1H, overlap),  6.49 (d, J = 2.0 Hz, 1H, overlap), 
6.42 (d, J = 2.0 Hz, 1H, overlap), 6.27 (d, J = 15.9 Hz, 1H) 4.95-4.84 (m, 1H), 3.83 (s, 3H), 3.74 (s, 3H), 
3.40 (d, J = 15.1 Hz, 1H), 3.36 (d, J = 15.1 Hz, 1H), 2.39-2.29 (m, 1H), 2.24-2.13 (m, 1H), 1.94-1.75 (m, 
2H), 1.54-1.39 (m, 2H), 1.16 (d, J = 6.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 198.6 (C), 170.7 (C), 
161.1 (C), 157.4 (C), 156.6 (CH), 133.4 (CH), 133.0 (C), 122.7 (C), 106.7 (CH), 98.1 (CH), 73.1 (CH), 56.0 
(CH3), 55.6 (CH3), 39.7 (CH2), 34.4 (CH2), 34.2 (CH2), 24.6 (CH2), 20.5 (CH3); IR (film): ṽ = 2937, 2841, 
1722, 1650, 1602, 1582, 1455, 1422, 1310, 1271, 1200, 1156, 1080, 1053, 1039, 974, 949, 913, 833, 
728 cm-1; MS (EI): m/z (%): 319 (20), 318 (100), 301 (17), 275 (19), 259 (5), 248 (5), 246 (8), 231 (9), 
223 (16), 218 (9), 217 (15), 206 (5), 205 (26), 204 (15), 195 (16), 192 (6), 191 (8), 189 (8), 179 (5), 178 
(26), 177 (6), 176 (8), 175 (6), 161 (7), 135 (5), 115 (5), 77 (5), 55 (8), 41 (7); HRMS (ESI): m/z calcd for 
C18H22O5Na [M+Na]
+: 341.1359; found 341.1362. 
α,β-Dehydrocurvularin (27): A suspension of aluminum powder (61 mg, 2.26 mmol) and I2 (381 mg, 
1.50 mmol) in toluene (1 mL) was stirred at 90 °C for 20 min. After cooling to 
ambient temperature, the mixture was allowed to settle and the solution 
transferred to a stirred solution of compound 35 (24 mg, 0.075 mmol) and TBAI 
(5.5 mg, 0.015 mmol) in toluene (1 mL) at 0 °C. The resulting mixture was stirred 
for 20 min at 0 °C, before the reaction was quenched with sat. aq. Na2S2O3. Ethyl acetate and sat. aq. 
Rochelle´s salt were added and the biphasic mixture was vigorously stirred for 10 min. The aqueous 
layer was extracted with ethyl acetate and the combined organic phases were dried over Na2SO4 and 
evaporated. The residue was purified by flash chromatography (hexanes/EtOAc, 80/20  65/35) to 
give product 27 as yellowish plates (13 mg, 60%). Mp = 209-211 °C 12 (218-220 °C, ref.13);  20D
= 65.5° (c = 0.9, EtOH) (  20D  = 64.1°, ref.
13); 1H NMR (600 MHz, [D6]-acetone): δ = 12.41 (s, 1H), 
9.27 (s, 1H), 6.80 (dt, J = 15.4, 1.4 Hz, 1H), 6.59 (ddd, J = 15.4, 9.1, 4.5 Hz, 1H), 6.37 (d, J = 2.4 Hz, 1H), 
6.31 (d, J = 2.4 Hz, 1H), 4.76-4.70 (m, 1H), 4.10 (d, J = 17.8 Hz, 1H), 3.63 (d, J = 17.8 Hz, 1H), 2.47-2.41 
(m, 1H), 2.39-2.32 (m, 1H), 2.03-1.97 (m, 1H), 1.89-1.82 (m, 1H), 1.71-1.59 (m, 2H), 1.19 (d, J = 6.4 Hz, 
3H); 13C NMR (150 MHz, [D6]-acetone): δ = 197.2 (C), 171.8 (C), 166.0 (C), 163.0 (C), 149.6 (CH), 139.5 
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C, 132.5 (CH), 115.5 (C), 113.7 (CH), 102.8 (CH), 72.8 (CH), 43.7 (CH2), 34.6 (CH2), 33.1 (CH2), 24.9 
(CH2), 20.2 (CH3); IR (film): ṽ = 3348, 2979, 2927, 1699, 1621, 1579, 1441, 1367, 1332, 1306, 1233, 
1199, 1174, 159, 1139, 1120, 1069, 1048, 1027, 1011, 984, 837, 780, 682 cm-1; MS (EI): m/z (%):291 
(18), 290 (100), 218 (12), 205 (10), 203 (54), 192 (10), 190 (20), 189 (11), 177 (27), 176 (17), 175 (23), 
167 (20), 166 (14), 164 (16), 163 (15), 161 (15), 150 (26), 147 (13), 121 (10), 115 (10), 81 (18), 77 (10), 
69 (23), 67 (11), 65 (11), 55 (19), 53 (11), 43 (10), 41 (17), 39 (15); HRMS (ESI): m/z calcd for 
C16H18O5Na [M+Na]
+: 313.1046; found 313.1044. 
 
Total Synthesis of ()-A26771B 
 
But-2-ynal (S9). 2-Butynol (10 mL, 132 mmol) was added to a vigorously stirred suspension of MnO2 
(120 g, 1.4 mol) in Et2O (100 mL) at 0°C and stirring was continued at ambient temperature 
for 12 h. Additional MnO2 (30 g, 350 mmol) was then added and the mixture stirred for 
additional 4 h. After filtration through a pad of Celite and careful evaporation of the filtrate 
at < 40°C bath temperature, the residue was distilled under vacuum to afford the title compound as a 
pale yellow liquid (2.2 g, 58%). 1H NMR (400 MHz, CDCl3): δ = 9.13 (br s, 1H), 2.05 ppm (d, J = 1.1 Hz, 
3H); 13C NMR (100 MHz, CDCl3): δ = 177.1, 95.2, 80.9, 4.1 ppm; IR (film): ṽ = 3981, 1691, 1242 cm
-1. 
The analytical and spectroscopic data are in agreement with those reported in the literature.14 
tert-Butyl-3-hydroxyhex-4-ynoate (S10). nBuLi (24 mL, 38.3 mmol, 1.6 M in hexane) was added 
dropwise to a solution of (iPr)2NH (5.4 mL, 38.3 mmol) in THF (65 mL) at 78 °C 
over the course of 1 h and the resulting mixture was stirred for an additional hour. 
A solution of tert-butyl acetate (5.2 mL, 28.3 mmol) in THF (25 mL) was added 
dropwise and the mixture stirred for 1 h before a solution of but-2-ynal S9 (2.2 g, 31.9 mmol) in THF 
(30 mL) was slowly added. The mixture was stirred for 1 h at that temperature before the reaction 
was quenched with MeOH (5 mL). The crude material was washed with aq. sat. NH4Cl, the aqueous 
phase was extracted with Et2O (3x), and the combined organic layers were washed with brine and 
dried over Na2SO4. The solvent was evaporated and the residue purified by flash chromatography 
(hexane/EtOAc, 9:1) to afford the title compound as a colorless oil (4.8 g, 82%). 1H NMR (400 MHz, 
CDCl3): δ = 4.68-4.63 (m, 1H), 3.10 (br s, 1H), 2.62 (s, 1H), 2.60 (d, J = 0.7 Hz, 1H), 1.82 (d, J = 2.2 Hz, 
3H), 1.57 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 170.9, 81.6, 81.2, 78.6, 59.1, 43.2, 28.1, 3.5; IR (film): 
ṽ = 3449, 2979, 2923, 1728, 1367, 1255, 1149, 1050, 1012, 845, 732 cm-1; MS (EI) m/z (%): 57 (15), 56 
(54), 55 (22), 41 (100), 40 (19), 369 (51); HRMS (ESI): m/z: calcd. for C10H16O3Na [M
++Na]: 207.0990, 
found 207.0992.  
tert-Butyl-3-(benzoyloxy)hex-4-ynoate (S11). Benzoyl chloride (2.8 mL, 24 mmol) was added 
dropwise to a solution of tert-butyl-3-hydroxyhex-4-ynoate S10 (2.7 g, 14.6 mmol) 
in dichloromethane (20 mL) and pyridine (10 mL) at 0 °C. The mixture was stirred 
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at room temperature for 6 h before the reaction was quenched with aq. sat. NH4Cl. The aqueous 
phase was extracted with dichloromethane (3x), the combined organic layers were dried over Na2SO4 
and the solvent was evaporated. The residue was purified by flash chromatography (hexane/EtOAc, 
19:1) to afford the title compound as a colorless oil (4.1 g, 98%). 1H NMR (400 MHz, CDCl3): δ = 8.04 
(dd, 2H, J = 8.4, 1.3 Hz), 7.56 (tt, 1H, J = 7.5, 1.3 Hz), 7.43 (t, 2H, J = 8.0 Hz), 5.89 (ddq, 1H, J = 8.6, 5.6, 
2.1 Hz), 2.90 (dd, 1H, J = 15.4, 8.5 Hz), 2.78 (dd, 1H, J = 15.5, 5.6 Hz), 1.83 (d, 3H, J = 2.2 Hz), 1.40 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ = 168.4, 165.5, 133.3, 129.9, 129.8, 128.5, 82.7, 81.5, 75.9, 61.7, 
42.1, 28.2, 3.9 ppm; IR (film): ṽ = 3015, 2978, 2924, 1724, 1452, 1367, 1264, 1147, 1095, 1098, 1025, 
997, 709 cm-1; MS (EI) m/z (%): 288 (0.2), 187 (15), 105 (100), 93 (14), 77 (22), 57 (24); HRMS (ESI): 
m/z: calcd. for C17H20O4Na [M
++Na]: 331.1256, found 331.1254.     
3-(Benzoyloxy)hex-4-ynoic acid (S12). Trifluoroacetic acid (3.2 mL, 43 mmol) was added to a solution 
of tert-butyl ester S11 (2.5 g, 8.6 mmol) in dichloromethane (85 mL) at 0 °C and the 
mixture was stirred for 12 h at ambient temperature. Aq. sat. NaHCO3 was added 
until a neutral pH was reached, the layers were separated and the aqueous phase 
was extracted with dichloromethane (3x). The combined organic layers were dried over Na2SO4, the 
solvent was evaporated, and the residue was purified with flash chromatography (hexane/ethyl 
acetate, 7:3  6:4, 1% of HOAc) to afford the title compound as a white solid (2.0 g, 99%). mp = 102-
103 °C; 1H NMR (400 MHz, CDCl3): δ = 10.97 (br s, 1H), 8.03 (dd, 2H, J = 8.3, 1.2 Hz), 7.60 (tt, 1H, J = 
7.5, 1.4 Hz), 7.43 (dd, 2H, J = 8.2, 7.4 Hz), 5.92 (ddq, 1H, J = 7.6, 5.5, 2.1 Hz), 3.01 (dd, 1H, J = 16.4, 8.1 
Hz), 2.93 (dd, 1H, J = 16.3, 5.5 Hz), 1.83 (d, 3H, J = 2.2 Hz); 13C NMR (100 MHz, CDCl3): δ = 175.0, 
165.5, 133.5, 130.1, 129.8, 128.6, 83.2, 75.5, 61.0, 40.3, 3.9; IR (film): ṽ = 3064, 2923, 2632, 1712, 
1451, 1417, 1265, 1176, 1156, 1096, 1069, 1026, 997, 707 cm-1; MS (EI) m/z (%): 233 (0.1), 232 (0.2), 
187 (12), 122 (49), 105 (100), 77 (48), 66 (13), 65 (10), 51 (22), 39 (21); HRMS (ESI): m/z: calcd. for 
C13H12O4Na [M
++Na]: 255.0626, found 255.0628.  
11-Bromo-2-undecyn (S13). Tf2O (4.2 mL, 25.2 mmol) was added to a solution of 7-bromoheptanol 
(4.4 g, 20.5 mmol) in dichloromethane (80 mL) and pyridine (2 mL, 25.2 
mmol) at 0°C and the resulting mixture was stirred for 30 min at this 
temperature and for 15 minutes at RT. For work up, the mixture was diluted with hexane (80 mL) and 
filtered through a pad of Celite. The filtrate was evaporated and the residue dissolved in THF (80 mL). 
Next, a suspension of propinyl lithium (1.0 g, 22 mmol) in THF (20 mL + 20 mL to rinse) was added via 
cannula at 78 °C and the mixture stirred for 20 minutes at that temperature before it was allowed 
to reach 0 °C. After stirring for 1 h, the reaction was quenched with aq. sat. NH4Cl, the layers were 
separated and the aqueous phase was extracted with EtOAc (3x). The combined organic layers were 
dried over Na2SO4, the solvent was evaporated, and the residue was purified by flash 
chromatography (hexane/EtOAc, 15:1) to afford the title compound as a colorless liquid (3.3 g, 67%). 
1H NMR (400 MHz, CDCl3): δ = 3.40 (t, 2H, J = 6.8 Hz), 2.11 (tq, 2H, J = 7.0, 2.6 Hz), 1.85 (quint, 2H, J = 
7.6 Hz), 1.77 (t, 3H, J = 2.6 Hz), 1.49-1.27 (m, 10H); 13C NMR (100 MHz, CDCl3): δ = 79.5, 75.6, 33.2, 
29.2, 29.2, 29.0, 28.9, 28.3, 18.9, 3.7; IR (film): ṽ = 2929, 2855, 1462, 1436, 1268, 1247, 724 cm-1. MS 
(EI) m/z (%): 233 (0.04), 232 (0.4), 231 (0.06), 230 (0.21), 135 (10.3), 109 (31), 107 (12), 96 (20), 95 
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(100), 93 (25), 91 (10), 82 (16), 81 (63), 79 (38), 77 (11), 69 (20), 68 (50), 67 (90), 55 (74), 54 (40), 53 
(30), 43 (16), 41 (59), 39 (28), 27 (15). HRMS (ESI): m/z: calcd. for C11H19Br+H [M
++H]: 230.0670, 
found 230.0670.  
HRMS (ESI): m/z: calcd. for C27H48O3SiNa [M
++Na]: 471.3265, found: 471.3269. 
(S)-1-Methyl-11-tridecynol (ent-37). 11-Bromo-2-undecyne (2.8 g, 12.4 mmol) was added dropwise 
to a suspension of Mg (1.5 g, 62 mmol, pre-activated with 2 x 50 µL 
of dichloroethane) in THF (15 mL) at room temperature and the 
resulting mixture stirred for 4 h. The suspension was transferred via cannula into a solution of (S)-
propenoxide (840 µL, 12 mmol) and CuI (228 mg, 1.2 mmol) in THF (30 mL) at 78°C. The mixture was 
stirred for 10 h while slowly reaching ambient temperature before it was quenched with aq. sat. 
NH4Cl and ethyl acetate. The aqueous phase was extracted with EtOAc (3x), the combined organic 
layers were dried over Na2SO4, the solvent was evaporated, and the residue was purified by flash 
chromatography (hexane/EtOAc, 9:1) to afford the title compound as a colorless oil (1.9 g, 79%). 
 20D = + 6.8 (c = 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 3.78 (m, 1H), 2.11 (dq, 2H, J = 6.9, 2.6 Hz), 
1.78 (t, 3H, J = 2.6 Hz), 1.50-1.29 (m, 17H), 1.18 (d, 3H, J = 6.1 Hz); 13C NMR (100 MHz, CDCl3): δ = 
79.6, 75.5, 68.4, 39.6, 29.9, 29.8, 29.7, 29.4, 29.3, 29.1, 26.0, 23.7, 19.0, 3.7; IR (film): ṽ = 3340, 2968, 
2920, 2854, 1727, 1462, 1373, 1289, 1125, 1071, 933, 843, 721 cm-1; MS (EI) m/z (%): 210 (0.03), 135 
(22), 121 (28), 109 (24), 108 (18), 107 (25), 96 (19), 95 (89), 94 (25), 93 (47), 83 (13), 82 (24), 81 (88), 
80 (11), 79 (50), 71 (13), 69 (38), 68 (85), 67 (93), 57 (15), 55 (100.00), 57 (23), 53 (25), 45 (98), 43 
(39), 41 (68), 39 (17), 29 (20), 27 (13); HRMS (ESI): m/z: calcd. for C14H27O+H [M
++H]: 211.2060, 
found: 211.2062.  
The enantiomer (37) was prepared analogously in 84% yield from (R)-propenoxide;  20D = + 7.0 (c = 
0.8, CHCl3) 
Compound 40. Ph3P (2.0 g, 7.8 mmol) and DIAD (1.5 mL, 7.8 mmol) were added to a solution of 1-
methyl-11-tridecynol ent-37 (1.6 g, 6.5 mmol) and 3-(benzoyloxy)hex-4-ynoic 
acid S9 (1.5 g, 7 mmol) in toluene (80 mL) at 0 °C. The mixture was stirred at 
ambient temperature for 1 h before the solvent was evaporated. The residue 
was purified by flash chromatography (hexane/EtOAc, 20:1) to afford the title 
compound as a colorless syrup (2.8 g, 98%, diastereomeric mixture). 1H NMR (400 MHz, CDCl3): δ = 
8.03 (d, 2H, J = 7.4), 7.55 (tt, 1H, J = 7.3, 1.6 Hz), 7.42 (t, 2H, J = 7.8 Hz), 5.94-5.91 (m, 1H), 4.92 (m, 
1H), 2.99 (ddd, 1H, J = 15.6, 8.5, 1.9 Hz), 2.84 (dd, 1H, J = 15.5, 5.5 Hz), 2.13-2.07 (m, 2H), 1.83 (d, 3H, 
J = 2.1 Hz), 1.78 (tt, 3H, J = 2.6, 0.9 Hz), 1.55-1.13 (m, 19H); 13C NMR (100 MHz, CDCl3): δ =  168.9 (2 
dia.), 165.4 (2 dia.), 133.4 (2 dia.), 130.0 (2 dia.), 128.6 (2 dia.), 128.6 (2 dia.), 82.9 (2 dia.), 79.6 (2 
dia.), 75.9 (2 dia.), 75.5 (2 dia.), 72.0 (2 dia.), 61.6 (1 dia.), 61.6 (1 dia.), 41.2 (1 dia.), 41.2 (1 dia.), 
36.1 (2 dia.), 29.7 (1 dia.), 29.6 (1 dia.), 29.6 (1 dia.), 29.6 (1 dia.), 29.4 (1 dia.), 29.3 (1 dia.), 29.3 (2 
dia.), 29.1 (2 dia.), 25.6 (1 dia.), 25.5 (1 dia.), 20.1 (1 dia.), 20.1 (1 dia.), 14.4 (2 dia.), 3.9 (2 dia.), 3.7 
(2 dia.); IR (film): ṽ = 2927, 2855, 1730, 1452, 1377, 1266, 1176, 1105, 1096, 1069 1026, 998, 711 cm-
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1; MS (EI) m/z (%): 424 (0.9), 187 (10), 111 (11), 105 (100), 95 (11), 93 (15), 77 (13), 67 (9), 55 (12), 41 
(8); HRMS (ESI): m/z: calcd. for C27H36O4Na [M
++Na]: 447.2505; found: 447.2506.  
Compound 41. Catalyst 2 (120 mg, 0.09 mmol) was added to a suspension of compound 40 (800 mg, 
1.8 mmol) and powdered MS 5Å (12 g) in toluene (1.5 L) at ambient temperature. 
The suspension was stirred at 80 °C for 3 h before it was cooled to ambient 
temperature and filtered through a plug of silica, which was carefully rinsed with 
hexane/ethyl acetate (1:1). The combined filtrates were evaporated and the 
residue purified by flash chromatography (hexane/EtOAc, 30:1) to yield the title compound as a 
viscous oil (630 mg, 95%, 2 diastereomers). 1H NMR (400 MHz, CDCl3): δ = 8.08-8.05 (m, 4H, 2 dia.), 
7.56 (t, 2H, J = 7.4 Hz, 2 dia.), 7.44 (d, 2H, J = 7.7 Hz, 1 dia.), 7.42 (d, 2H, J = 7.6 Hz, 1 dia.), 5.98-5.93 
(m, 2H, 2 dia.), 5.12-5.06 (m, 1H, 1 dia.), 5.02 (dq, 1H, J = 7.1, 6.2 Hz, 1 dia.), 2.99-2.88 (m, 3H, 2 dia.), 
2.84 (dd, 1H, J = 14.1, 9.6 Hz, 1 dia.), 2.35-2.19 (m, 4H, 2 dia.), 1.78-1.61 (m, 2H, 2 dia.), 1.52-1.13 (m, 
30H, 2 dia.), 1.24 (d, 3H, J = 6.2 Hz, 1 dia.), 1.22 (d, 3H, J = 6.4 Hz, 1 dia.); 13C NMR (100 MHz, CDCl3): δ 
= 169.1 (1 dia.), 168.2 (1 dia.), 165.6 (1 dia.), 165.4 (1 dia.), 133.5 (1 dia.), 133.4 (1 dia.), 130.1 (1 
dia.), 130.0 (1 dia.), 128.6 (2 dia.), 128.6, (2 dia.), 87.7 (1 dia.), 87.0 (1 dia.), 77.5 (1 dia.), 76.6 (1 dia.), 
71.3 (1 dia.), 70.7 (1 dia.), 61.8 (1 dia.), 61.7 (1 dia.), 41.6 (1 dia.), 40.5 (1 dia.), 35.6 (1 dia.), 35.5 (1 
dia.), 27.5 (2 dia.), 27.1 (1 dia.), 27.1 (1 dia.), 27.0 (1 dia.), 27.0 (1 dia.), 26.8 (1 dia.), 26.7 (1 dia.), 
26.7 (2 dia.), 26.6 (1 dia.), 26.5 (1 dia.), 26.3 (1 dia.), 26.1 (1 dia.),  24.5 (1 dia.), 24.3 (1 dia.), 20.5 (1 
dia.), 20.4 (1 dia.), 18.4 (1 dia.), 18.3 (1 dia.); IR (film): ṽ = 2976, 2931, 2858, 1724, 1452, 1290, 1265, 
1250, 1175, 1096, 1103, 1069, 1026, 711 cm-1; MS (EI) m/z (%): 370 (0.3), 106 (8), 105 (100), 77 (16), 
55 (7), 43 (5), 41 (9); HRMS (ESI): m/z: calcd. for C23H30NaO4 [M
++Na]: 393.2035, found: 393.2036.  
Compound 43. Commercial Lindlar catalyst (85 mg) and quinoline (85 µL) were added to a solution of 
compound 7 (630 mg, 1.7 mmol) in hexane (85 mL). The suspension was stirred 
under H2 (1 atm.) for 2 h before it was filtered through a pad of silica, which was 
rinsed with hexane/ethyl acetate (1:1). The combined filtrates were evaporated and 
the residue was purified by flash chromatography (hexane:EtOAc, 35:1) to afford the title compound 
as a colorless oil (630 mg, 99%, mixture of 2 diastereomers). 1H NMR (400 MHz, CDCl3): δ = 8.04-8.00 
(m, 4H, 2 dia.), 7.54-7.50 (m, 2H, 2 dia.), 7.41 (t, 4H, J = 7.8 Hz, 2 dia.), 6.29 (tdd, 1H, J = 10.2, 3.3, 0.7 
Hz, 1 dia.), 6.22 (tdd, 1H, J = 9.3, 4.2, 0.6 Hz, 1 dia.), 5.70 (dtd, 1H, J = 10.3, 6.4, 0.5 Hz, 1 dia.), 5.63 
(dt, 1H, J = 10.3, 6.4 Hz, 1 dia.), 5.48-5.40 (m, 2H, 2 dia.), 4.94-4.91 (m, 1H, 1 dia.), 4.90-4.83 (m, 1H, 1 
dia.), 2.89 (dd, 1H, J = 11.9, 10.3 Hz, 1 dia.), 2.85 (dd, 1H, J = 9.7, 8.7 Hz, 1 dia.), 2.61-2.57 (m, 3H, 2 
dia.), 2.52-2.43 (m, 1H, 1 dia.), 2.16-2.08 (m, 1H, 1 dia.), 2.03-1.96 (m, 1H, 1 dia.), 1.64-1.31 (m, 32H, 
2 dia.), 1.22 (d, 3H, J = 6.3 Hz, 1 dia.), 1.02 (d, 3H, J = 6.2 Hz, 1 dia.); 13C NMR (100 MHz, CDCl3): δ = 
169.9 (1 dia.), 169.3 (1 dia.), 165.7 (1 dia.), 165.7 (1 dia.), 135.2 (1 dia.), 135.0 (1 dia.), 133.1 (1 dia.), 
133.0 (1 dia.), 130.7 (1 dia.), 130.5 (1 dia.), 129.9 (1 dia.), 129.7 (1 dia.), 128.5 (1 dia.), 128.5 (1 dia.), 
127.4 (1 dia.), 127.0 (1 dia.), 72.3 (1 dia.), 71.5 (1 dia.), 68.3 (1 dia.), 68.0 (1 dia.), 41.8 (1 dia.), 41.1 (1 
dia.), 34.9 (1 dia.), 34.4 (1 dia.), 27.7 (1 dia.), 27.6, 27.6 (1 dia.), 27.4 (1 dia.), 27.1 (1 dia.), 27.1 (1 
dia.), 27.0 (1 dia.), 27.0 (1 dia.), 26.9 (1 dia.), 26.9 (1 dia.), 26.5 (1 dia.), 26.4 (1 dia.), 23.2 (1 dia.), 
22.9 (1 dia.), 23.2 (1 dia.), 22.9 (1 dia.), 20.1 (1 dia.), 20.0 (1 dia.); IR (film): ṽ = 2980, 2928, 2857, 
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1724, 1451, 1272, 1175, 1108, 1068, 1024, 711 cm-1; MS (EI) m/z (%): 372 (6), 267 (22), 105 (100), 77 
(17), 55 (11), 41 (11); HRMS (ESI): m/z: calcd. for C23H32NaO4 [M
++Na]: 395.2190, found: 395.2193.  
Compound 44. DBU (1.3 mL) was added to a solution of compound 43 (630 mg, 1.7 mmol) in toluene 
(34 mL) at 0°C. The reaction was stirred for 6 h at ambient temperature before the 
solvent was evaporated and the residue purified by flash chromatography 
(hexane/EtOAc, 35:1) to afford the title compound as a colorless oil (413 mg,  97%). 
 20D = 17.0 (c = 2.0, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.58 (ddd, 1H, J = 15.3, 
11.6, 0.8 Hz), 6.15 (t, 1H, J = 11.2 Hz), 5.88 (dt, 1H, J = 10.8, 6.5 Hz), 5.80 (d, 1H, J = 15.4 Hz), 4.83 (m, 
1H), 2.59-2.49 (m, 1H), 2.03-1.94 (m, 1H), 1.62-1.55 (m, 2H), 1.52-1.16 (m, 14H), 1.28 (d, 3H, J = 6.2 
Hz); 13C NMR (100 MHz, CDCl3): δ = 166.8, 141.0, 138.8, 127.2, 122.1, 71.9, 35.6, 27.7, 27.7, 27.3, 
27.3, 26.8, 26.6 26.3, 23.4, 20.6 ppm. IR (film): ṽ = 2928, 2857, 1710, 459, 1257, 1122, 993 cm-1; MS  
(EI) m/z (%): 250 (16), 152 (10), 149 (12), 136 (10), 135 (20), 133 (11), 124 (15), 123 (18), 122 (12), 
121 (25), 119 (11), 110 (23), 109 (31), 108 (17), 107 (30), 99 (17), 97 (40), 96 (48), 95 (62), 94 (34), 93 
(30), 91 (19), 83 (25), 82 (57), 81 (100), 80 (50), 77 (22), 69 (31), 68 (38), 67 (75), 66 (34), 65 (15), 57 
(11), 55 (68), 54 (25), 53 (23), 43 (26), 41 (57), 39 (18), 29 (14). HRMS (ESI): m/z: calcd. for C16H26O2Na 
[M++Na]: 273.1827, found 273.1825. The spectroscopic data are in agreement with those reported in 
the literature.15 
Compound 45. AD-mix β (800 mg), NaHCO3 (143 mg, 0.52 mmol), methanesulfonamide (55 mg, 0.58 
mmol) and K2OsO4·2H2O (15 mg, 0.04 mmol) were successively added to a 
solution of compound 10 (150 mg, 0.58 mmol) in tBuOH/H2O (10 mL, 1:1) at 0 °C. 
The suspension was stirred for 18 h before the reaction was quenched with aq. 
sat. Na2SO3 and EtOAc. The aqueous phase was extracted with EtOAc (3x), the 
combined organic layers were dried over Na2SO4 and evaporated, and the residue was purified by 
flash chromatography (hexanes/EtOAc, 3:2  1:1) to afford the title compound as a white solid (133 
mg, 81%); dr > 95:5 (HPLC, 150 mm YMC-Pack ODS-A, 5 µm, 12 nm, 4.5 mm, MeOH:H2O = 65:35, 0.8 
mL/min, 308 K, 13.8 MPa, 220 nm, tR (major) = 21.1 min, tR (minor) = 22.3 min).  20D = 40.5 (c = 0.5 
CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 6.90 (dd, 1H, J = 15.9, 5.4 Hz), 6.09 (dd, 1H, J = 15.9, 1.7 Hz), 
5.04-4.99 (m, 1H), 4.51-4.48 (m, 1H), 3.74-3.71 (m, 1H), 2.22 (br s, 2H), 1.66-1.14 (m, 18H), 1.26 (d, 
3H, J = 6.2 Hz); 13C NMR (100 MHz, CDCl3): δ = 166.1, 145.4, 123.0, 74.3, 74.2, 71.5, 35.8, 29.9, 28.0, 
27.8, 27.4, 26.3, 26.3, 24.0, 23.4, 20.7; IR (film): ṽ = 3423, 2928, 2857, 1716, 1458, 1271, 1171, 1128, 
1072, 984 cm-1; MS (EI) m/z (%): 284 (0.5), 102 (100.00), 84 (35), 55 (15), 43 (11), 41 (15); HRMS (ESI): 
m/z: calcd. for C16H28O4Na [M
++Na]: 307.1881, found: 307.1880.  
Compound 46. p-TsOH (99 mg, 0.52 mmol) and TEMPO (82 mg, 0.52 mmol) were added to a solution 
of diol 45 (75 mg, 0.26 mmol) in dichloromethane at 0°C. The mixture was stirred 
for 5 h at room temperature before the solvent was evaporated. The residue was 
purified by flash chromatography (hexanes:EtOAc, 7:1 to 5:1) to give a beige solid 
that was recrystallized from hexane to afford the title compound as a white 
                                                 
15
  T. Fuijisawa, N. Okada, M. Takeuchi, T. Sato. Chem. Lett. 1983, 12, 1271-1272. 
S-32 
 
crystalline material (46 mg, 62%). Mp = 83-84°C, [mp = 84-85 °C, cf. ref.16];  20D = +22.1 (c = 0.7 
CHCl3), [  20D = + 22.4 (c = 1.0,  CHCl3), cf. ref.
16]; 1H NMR (400 MHz, CDCl3): δ = 7.25 (d, 1H, J = 15.9 
Hz), 6.79 (d, 1H, J =15.9 Hz), 5.20-5.13 (m, 1H), 4.53 (t, 1H, J = 4.4 Hz), 3.45 (br s, 1H), 1.86-1.81 (m, 
1H), 1.76-1.68 (m, 1H), 1.55-1.46 (m, 3H), 1.37-1.07 (m, 11H), 1.30 (d, 3H, J = 6.3 Hz), 1.01-093 (m, 
2H); 13C NMR (100 MHz, CDCl3): δ = 201.6, 165.2, 135.1, 132.7, 76.6, 72.9, 34.4, 31.3, 28.3, 27.5, 27.3, 
27.0, 23.6, 20.9, 19.9; IR (film): ṽ = 3491, 2926, 2856, 1714, 1697, 1458, 1354, 1282. 1187, 1128, 
1057, 978 cm-1; MS (EI) m/z (%): 282 (0.8), 100 (100), 82 (15), 55 (20), 43 (13), 41 (18). HRMS (ESI): 
m/z: calcd. for C16H26O4Na [M
++Na]: 305.1724, found 305.1724. The analytical and spectroscopic data 
are in agreement with those reported in the literature.16  
()-A26771B (36). Succinic anhydride (365 mg, 0.035 mmol) and DMAP (24 mg, 0.02 mmol) were 
added to a solution of compound 12 (50 mg, 0.018 mmol) in CH2Cl2 (3 
mL) at 0 °C. The mixture was stirred for 18 h at room temperature 
before the solvent was evaporated and the residue was purified by 
flash chromatography (CH2Cl2  CH2Cl2/MeOH (95:5)) to afford the title 
compound as a white solid (55 mg, 71%). Mp = 122-123; [mp = 121-122 °C, ref.16; Mp = 125-126 °C, 
ref.17; Mp = 124-125 °C, ref.18];  20D = 14.3 (c = 2.0 MeOH),  
20
D = 13.9 (c = 0.28, MeOH); ( 
20
D = 
13.2 (c = 0.19, MeOH), ref.3); 1H NMR (400 MHz, CDCl3): δ = 7.22 (d, 1H, J = 15.7 Hz), 6.76 (d, 1H, J = 
15.7 Hz), 5.33 (t, 1H, J = 5.7 Hz), 5.18-5.11 (m, 1H), 2.79-2.73 (m, 4H), 1.97-1.83 (m, 2H), 1.74-1.66 (m, 
1H), 1.60-1.50 (m, 1H), 1.48-1.10 (m, 14H), 1.29 (d, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 
195.6, 177.3, 171.6, 165.0, 135.4, 132.7, 78.1, 72.8, 34.7, 29.0, 28.9, 28.8, 28.2, 27.4, 27.3, 27.1, 23.7, 
22.4, 20.0; IR (film): ṽ = 2928, 2857, 1740, 1700, 1379, 1357, 1300, 1197, 1163 cm-1; MS (EI) m/z (%): 
282 (16), 181 (18), 112 (13), 111 (12), 100 (100), 99 (42), 98 (25), 95 (16), 83 (19), 82 (24), 81 (15), 69 
(16), 67 (14), 56 (31), 55 (71), 43 (30), 42 (12), 41 (42), 28 (31). HRMS (ESI): m/z: calcd. for C20H30O7Na 
[M++Na]: 405.1882, found 405.1884. The analytical and spectroscopic data are in agreement with 
those reported in the literature.15,16,17,18  
Compound 42. DBU (113 µL, 0.76 mmol) was added to a solution of alkyne 41 (0.38 mmol) in toluene 
(4 mL) at 0 °C.  The mixture was stirred overnight at ambient temperature before 
the solvent was evaporated. The residue was purified by flash chromatography 
(hexane/EtOAc, 40:1  30:1) and then by HPLC (50 mm Zorbax Eclipse C18, 1.8 µm, 
3 mm, MeOH:H2O, 90:1, 0.65 mL/min, 308 K, 25.2 MPa,  = 220 nm) in order to separate E-42 from 
small amounts of Z-42.  
Major Isomer E-42: 1H NMR (400 MHz, CDCl3): δ = 6.74 (dt, 1H, J = 15.9, 2.3 Hz), 6.14 (d, 1H, J = 15.8 
Hz), 5.03-4.95 (m, 1H), 2.39 (td, 2H, J = 6.5, 2.2 Hz), 1.61-1.50 (m, 4H), 1.42-1.37 (m, 2H), 1.33-1.26 
(m, 10H), 1.23 (d, 3H, J = 6.3 Hz). 13C NMR (100 MHz, CDCl3): δ = 166.1, 130.1, 126.0, 100.8, 78.4, 
71.5, 36.2, 29.6, 29.5, 29.3, 28.6, 28.3, 25.2, 20.4, 19.9; IR (film): ṽ = 2976, 2929, 2855, 1714, 1714, 
                                                 
16
  J. Gebauer, S. Blechert, J. Org. Chem. 2006, 71, 2021-2025.  
17
  K. Tatsuta, Y. Amemiya, Y. Kanemura, M. Kinoshita, Bull. Chem. Soc. Jpn. 1982, 55, 3248-3253.  
18
  K. H. Michel, P. V. Demarco, R. Nagarajan, J. Antibiot. 1977, 30, 571-575.  
S-33 
 
1615, 1462, 1297, 1280, 1254, 1178, 1157, 961, 859 cm-1; MS (EI) m/z (%): 248 (23), 151 (53), 147 
(35), 133 (54), 121 (29), 120 (23), 119 (65), 117 (16), 110 (23), 108 (24), 107 (43), 106 (26), 95 (22), 94 
(100), 93 (50), 92 (56), 91 (93), 81 (35), 80 (87), 79 (77), 78 (30), 77 (43), 67 (45), 66 (34), 65 (44), 64 
(36), 63 (33), 55 (26), 51 (22), 43 (21), 41 (67), 39 (35), 29 (24); HRMS (ESI): m/z: calcd. for C16H24NaO2 
[M++Na]: 271.1668, found: 271.1668.  
Minor Isomer Z-42: 1H NMR (400 MHz, CDCl3): δ = 6.05 (br s, 2H), 5.28-5.21 (m, 1H), 2.53 (ddd, 1H, J 
= 17.4, 6.5, 4.5 Hz), 2.33 (ddd, 1H, J = 17.5, 8.9, 4.1 Hz), 1.58-1.16 (m, 16H), 1.24 (d, 3H, J = 6.1 Hz); 
13C NMR (100 MHz, CDCl3): δ = 164.3, 128.3, 122.5, 102.4, 68.5, 35.6, 27.2, 26.8, 26.7, 26.1, 25.9, 
24.4, 20.3, 19.4; IR (film): ṽ = 2980, 2928, 2857, 1271, 1601, 1459, 1407, 1223, 1185, 1129 cm-1; 
HRMS (ESI): m/z: calcd. for C16H24NaO2 [M
++Na]: 271.1668, found 271.1670.  
Compound 38. (E)-Hex-2-en-4-ynoic acid (200 mg, 0.75 mmol), DMAP (232 mg, 1.9 mmol) and EDCI 
(364 mg, 1.9 mmol) were successively added to a solution of alcohol 37 (219 mg, 
1.9 mmol) in dichloromethane (10 mL) at 0°C. The mixture was stirred 1 h at 
ambient temperature before the reaction was quenched with aq. sat. NH4Cl. The 
layers were separated and the aqueous phase extracted with tert-butyl methyl 
ether (3x). The combined organic layers were dried over Na2SO4 and the solvent evaporated. Flash 
chromatography of the residue (hexane:EtOAc, 9:1) gave the title compound as a colorless oil (239 
mg, 83%). 1H NMR (400 MHz, CDCl3): δ = 6.69 (dq, 1H, J = 16.0, 2.3 Hz), 6.12 (d, 1H, J = 16.0 Hz), 4.96 
(sext, 1H, J = 6.3 Hz), 2.13-2.08 (m, 2H), 2.20 (d, 3H, J = 2.2 Hz), 1.78 (t, 3H, J = 2.4 Hz), 1.64-1.42 (m, 
4H), 1.36-1.20 (m, 12H), 1.23 (d, 3H, J = 6.2 Hz); 13C NMR (100 MHz, CDCl3): δ = 166.0, 130.2, 125.9, 
96.2, 79.6, 77.4, 75.5, 71.6, 36.1, 29.7, 29.6, 29.3, 29.1, 25.6, 20.2, 18.9, 4.9, 3.7; IR (film): ṽ = 2980, 
2928, 2855, 1712, 1621, 1461, 1301, 1267, 1181, 1165, 1129, 961 cm-1; MS (EI) m/z (%): 302 (1), 177 
(12), 163 (13), 119 (12), 111 (62), 95 (14), 93 (100=, 81 (14), 68 (12), 67 (15), 65 (15), 55 (20), 41 (14), 
39 (11). HRMS (ESI): m/z: calcd. for C20H30NaO2 [M
++Na]: 325.2136, found 325.2138.   
Cyclodimer 39. Complex 1 (22 mg, 0.033 mmol) was added to a suspension of compound 38 (100 mg, 
0.33 mmol) and powdered MS 5Å (1 g) in toluene (80 mL) and the resulting mixture was stirred at 
80 °C for 3 h. The suspension was filtered through a pad of silica which was rinsed with 
hexane/EtOAc (1:1). The combined filtrates were evaporated and the residue purified by flash 
chromatography (hexane/EtOAc, 50:1  40:1) to yield the title compound as a white solid (68 mg, 
83%).  20D = 27.4 (c = 0.9 CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 6.74 (d, 2H, J = 15.8 Hz), 6.14 (d, 2H, 
J = 15.9 Hz), 4.99 (m, 2H), 2.39 (m, 4H), 1-63-1.23 (m, 32H), 1.23 (d, 6H, J = 6.3 Hz); 13C NMR (100 
MHz, CDCl3): δ = 166.1, 130.1, 126.0, 100.8, 78.4, 71.5, 36.2, 29.6, 29.4, 29.3, 28.6, 28.6, 25.2, 20.4, 
19.9; IR (film): ṽ = 2930, 2861, 1699, 1620, 1305, 1189, 1163, 1130, 971 cm-1; (EI) m/z (%): 497 (31), 
496 (81), 451 (23), 343 (21), 325 (23), 249 (31), 148 (100), 231 (26), 230 (40), 205 (37), 203 (44), 201 
(20), 231 (26), 230 (40), 205 (37), 203 (44), 201 (20), 191 (42), 187 (20), 177 (29), 173 (22), 159 (20), 
151 (24), 147 (27), 133 (62), 131 (35), 123 (25), 121 (33), 118 (72), 117 (28), 107 (37), 105 (79), 95 
(34), 92 (49), 91 (94), 81 (59), 79 (90), 78 (22), 77 (31), 67 (65), 65 (30), 55 (92), 41 (42); HRMS (ESI): 
m/z: calcd. for C32H48NaO4 [M









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































C NMR (100 MHz, CDCl3)  
 


















































































































































































































C NMR (100 MHz, CDCl3) of Head-to-Tail Cyclodimer 


























































































H NMR (400 MHz, CDCl3) of 15-Heptadecynyl bu-2-ynoate (2) 
 
 

















C NMR (100 MHz, CDCl3)  
 





























































































































C NMR (100 MHz, CDCl3)  
 





































































































C NMR (75 MHz, CDCl3) of (10-Bromodecyloxy)(tert-butyl)dimethylsilane 
 

























































































C NMR (100 MHz, CDCl3)  
 



























































































































C NMR (100 MHz, CDCl3)  
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H NMR (400 MHz, CDCl3) (contains traces of the corresponding phosphine oxide formed during work up) 
 
 



































































































































C NMR (100 MHz, CDCl3) (contains traces of the corresponding phosphine oxide formed during work up) 
 
























































































































H NMR (400 MHz, CDCl3)  
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C NMR (100 MHz, CDCl3)  
 

























































































































































































































































































































C NMR (100 MHz, CDCl3) of tert-Butyl-3-hydroxyhex-4-ynoate 
 



























































H NMR (400 MHz, CDCl3) of tert-Butyl-3-(benzoyloxy)hex-4-ynoate 
 

























C NMR (100 MHz, CDCl3) of tert-Butyl-3-(benzoyloxy)hex-4-ynoate (3) 
 




































































































C NMR (100 MHz, CDCl3) of 3-(Benzoyloxy)hex-4-ynoic acid 
 




























































































































































































C NMR (100 MHz, CDCl3) of 1-Methyl-11-tridecynol 
 






















































































































C NMR (100 MHz, CDCl3)  
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C NMR (100 MHz, CDCl3)  
 
 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
1
9
.
8
5
2
0
.
4
3
2
5
.
2
3
2
8
.
2
8
2
8
.
5
5
2
9
.
2
9
2
9
.
4
4
2
9
.
6
3
3
6
.
2
4
7
1
.
4
9
7
8
.
4
1
1
0
0
.
8
3
1
2
6
.
0
4
1
3
0
.
0
9
1
6
6
.
0
6
